# **Our year in review**
## **Contents**
**Our impact**
1 Chair’s report and CEO welcome 4 2 Our team 5 3 Our strategy, vision and values 7 4 Our year in numbers 8 5 Objects and activities 9 6 Our linked charities 18 7 Achievements and performance – 22 supporting our hospitals, impact areas 26 8 Feedback from our NHS staff 9 Fundraising 27 10 Volunteers 35
**----- Start of picture text -----**
Financial review
**----- End of picture text -----**
11 Financial review
37
12 Principal risks and uncertainties
41
**About us**
43
- 13 Plans for future years 14 Structure, governance and management
- 44
47
15 Reference and administrative details
- 48
- 16 Statement of Trustee responsibilities and accounts
## **Auditor’s report and financial statements**
Independent auditor’s report to the 50 members of Leeds Hospitals Charity 52 Statement of financial activities for the year ended 31 March 2023 Balance sheet as at 31 March 2023 53 54 Statement of cash flows for the year ended 31 March 2023
Notes to the accounts
55
2
Annual report and financial statements 2022/23
Contents
Our impactl
Annual report and financial statements 2022123
Contents
Our Impact
## **Chair’s report and CEO welcome**
**Edward Ziff OBE DL, Chair of Leeds Hospitals Charity**
**Esther Wakeman CEO of Leeds Hospitals Charity**
I am delighted to present Leeds Hospitals Charity’s Annual Report for 2022/23. We’ve worked hard this year to continue providing vital funding during yet another difficult period, using our resources to mitigate the impact of the cost-of-living crisis and the after-effects of the pandemic for our hospitals.
Throughout the year, the generosity of our donors has been invaluable as we work towards our vision for Leeds Teaching Hospitals NHS Trust to be the best, in the healthiest city in the UK. Whatever form fundraising takes, it makes such a difference – and we’ve certainly seen a variety of events, activities and campaigns in 2022/23.
This year has given us a great deal to celebrate and share within these pages, thanks to the dedication and generosity of our staff, volunteers, and donors. We raised a huge amount of money for Leeds Teaching Hospitals NHS Trust – an incredible total given the challenges currently facing the sector – and we spent even more, boldly digging into our reserves to ensure this year’s funding had the biggest impact for patients and families yet.
Our supporters make everything we do possible, and that was no different in 2022/23. We saw astonishing acts of individual and community fundraising, nurtured new and existing corporate partnerships and major donors, and received much-needed boosts from legacies, grants, trusts and foundations. We also continued our long-term strategic work investing in
A real highlight was the British Transplant Games, which took place on home turf in Leeds in 2022 with our sponsorship. Elsewhere, other feats of athleticism and endurance were being undertaken in our name. Roundhay dad Mike Bates rowed an incredible 3,000 miles solo across the Atlantic to help paediatric patients like his son Gabe; Rugby League legend Kevin Sinfield OBE ran over 60 kilometres a day for seven days for the new Rob Burrow Centre for Motor Neurone Disease at Seacroft Hospital; and, thanks to Yorkshire Charity Clay Days, we were able to purchase an EPIQ CVx cardiac scanner for the neonatal ward at Leeds Children’s Hospital.
These are just a few of the many funding successes, all championed by our Chief Executive Esther
our lottery and regular giving programme and were heartened that so many loyal supporters chose to donate a regular monthly gift.
Our Patrons, Rob and Lindsey Burrow, have generously given their time and encouragement to our Rob Burrow Centre for Motor Neurone Disease Appeal which has been supported by so many people across Yorkshire and around the world. We are very grateful to Kevin Sinfield OBE who continues to fundraise and raise the profile of the new centre, bringing us closer to the project becoming a reality.
However big or small, every donation allows us to dramatically improve patient care at hospitals across Leeds – and it’s not just monetary gifts that have made a huge difference this year. At a time when
Wakeman and supported by the tireless efforts of our staff and volunteer teams. Thanks must go to them for all that they do to deliver the projects, campaigns and appeals that support the Charity’s work, as well as to my fellow Trustees, whose commitment and expertise have been invaluable in navigating these challenging times.
I hope that this Report will give you a small insight into the year’s many achievements and the tangible benefits Leeds Hospitals Charity provides for staff, patients and families across Leeds Teaching Hospitals NHS Trust. With the right funding and support, our NHS staff continue to deliver excellent service – I’m proud to be part of making that happen, and I hope you are too.
many are working longer hours to make ends meet, I am humbled by the fact that our volunteer team grew for the second year running! From managing our charity shops to manning events and campaigns, our volunteers are an essential part of the Leeds Hospitals Charity team. Along the way, they are ably supported by the Charity’s amazing staff, whose commitment continues to make me extremely proud.
As we enter the third year of our strategy, I’m grateful to each and every person who has helped us reach our goals so far. Because of you, we’ve weathered difficult circumstances and are now in a great position to build on 2022/23’s achievements, I’m excited for the work ahead and hopeful for our Charity’s future. Thank you!
Annual report and financial statements 2022/23
4
Contents
|**The Board**
**of Trustees**
The Board of Trustees is permitted a maximum
number of 15 Trustees. At 31 March 2023, the
charity had 12 trustees, 11 of whom are independent
lay Trustees appointed based on their skills and
experience. The fnal Trustee is nominated by Leeds
Teaching Hospitals NHS Trust, as required by the
Articles of Association of the Charity and Company.
**Our team**
**2**
Left to right: Edward Zif OBE DL, Dr Yvette Oade, Cllr Caroline Gruen, Prof Peter McWilliam,
Dame Linda Pollard DBE DL. Christopher Schofeld, Jasbir Athwal DL, Dean Hoyle, Dr Cassie Doherty,
Jonathan Grant, Sohail Ali, Mark Davies, Dr David Berridge and Lauren Glaister||
|---|---|
||**Name**
**Period of appointment**
**Number of Board meetings**
**attended 2022/23 (5)**|
||**Edward Zif OBE DL (Chair)**
From 22 November 2016
4|
||**Dr Yvette Oade (Vice Chair)**
From 24 November 2020
5|
||**Cllr Caroline Gruen**
From 22 November 2016
1|
||**Prof Peter McWilliam (Senior Independent Trustee)**
From 22 November 2016
4|
||**Dame Linda Pollard DBE DL (NHS Trustee)**
From 22 November 2016
2|
||**Christopher Schofeld**
From 1 July 2017
5|
||**Jasbir Athwal DL**
From 25 August 2020 to 3 May 2023
5|
||**Dean Hoyle**
From 25 August 2020 to 24 October 2022
Nil|
||**Dr Cassie Doherty**
From 24 November 2020
5|
||**Jonathan Grant**
From 9 February 2021
5|
||**Sohail Ali**
From 14 June 2021 to 26 October 2022
Nil|
||**Mark Davies**
From 14 June 2021
5|
||**Dr David Berridge**
From 14 June 2021
4|
||**Lauren Glaister**
From 9 September 2021
4|
Annual report and financial statements 2022/23
5
Contents
## **Executive Leadership team**
**Esther Wakeman** Chief Executive From 17 February 2020
**Paul Watkins** Director of Fundraising From 17 February 2020
**Eve Hartrick** Director of Finance and Corporate Services From 20 July 2020
**Sarah Griffin** Director of Communications From 1 April 2019 **Andrew Forsyth** Company Secretary From 22 June 2020
Charity mascot Ernie pays a special visit to the Leeds Children’s Hospital where Leeds Hospitals Charity has supported a wide range of projects and initiatives.
Annual report and financial statements 2022/23
6
Contents
## **Our strategy, vision and values**
Our vision for Leeds Hospitals Charity is for Leeds Teaching Hospitals to be the best hospital, in the healthiest city in the UK.
We exist to support NHS staff across all eight of the Trust’s hospital sites, helping them to deliver first-class care for over a million patients and their families each year. When it’s your loved one in hospital, you want the very best care, equipment, training and researchinformed treatment to be available for them – and so do our NHS staff. Donations from our supporters and generous legacies make that possible, allowing us to award grants all year round to fund the extra things that enhance the incredible care already provided.
Throughout 2022/23, we have continued to embed our three core values at the heart of all our activity to be transparent, transform lives and work together.
## **Strategic report**
For details of the Charity’s achievements and performance, refer to section 7: Achievements and performance – supporting our hospitals, impact areas, and section 8: Feedback from our NHS staff.
For our financial review, refer to section 11: Financial review and section 5: Grant funding.
For principal risks and uncertainties facing the Charity, refer to section 12: Principal risks and uncertainties.
## **Transparent**
Fostering a culture where honesty and openness are encouraged and valued. Managing expectations, doing what we say we’ll do and treating others the way we want to be treated.
## **Transform**
Making a difference not only through big changes but also through small acts of kindness. Embracing change, challenging the status quo, celebrating success and learning from mistakes; we are always looking for new ways to innovate and improve.
## **Together**
Collaborating with our partners towards shared goals. Helping others, accepting help ourselves and encouraging each other to be the best we can be. Empowering everyone to be their true selves, we value differences and recognise they make us stronger.
Annual report and financial statements 2022/23
7
Contents
> **4 Our year in numbers**
**281** applications approved **1** new on-site retail shop opened
**1** new scientific advisory panel established
**200 grants** awarded via the Employee Support Fund totalling nearly £100k
**----- Start of picture text -----**
Over £85k
awarded in lottery prizes
**----- End of picture text -----**
**----- Start of picture text -----**
Over 2,000
new lottery players
recruited
**----- End of picture text -----**
**£718k**
raised through gifts in wills
**£4.3m**
awarded to support research and Innovation
**£1m** for early year career researchers
**12,440 hours** donated by volunteers
**----- Start of picture text -----**
£13.2m
grant funding awarded
**----- End of picture text -----**
**£2.6m** awarded to the CHORAL paediatric research programme
**2.09m people 303** impacted through funding people volunteered at least once
**303**
**Over £100k** raised through the Christmas ‘Sponsor the Sparkle’ campaign
**£422k £6.8m** supporting our NHS staff
committed to the new Rob Burrow Centre for Motor Neurone Disease Contents 8
Annual report and financial statements 2022/23
## **Objects and activities**
## **Objects and purpose**
Leeds Hospitals Charity’s charitable Objects are:
- a) to further any charitable purpose or purposes relating to the general or specific purposes of the NHS Trust or the purposes of the Health Service;
- b) to promote, protect, preserve and advance all or any aspects of the health of the public;
- c) to advance and promote knowledge and education in medicine and health including by engaging in and supporting medical and health research and the dissemination of the useful results.
- The Charity fundraises actively in order to award grant funding to fulfil these charitable Objects.
## **Public benefit**
The Trustees have a duty to comply with Section 17 of the Charities Act 2011, which outlines the Charity Commission’s general guidance on public benefit. The Trustees confirm that Leeds Hospitals Charity has fulfilled this public benefit requirement and that this i s strongly embedded within the Charity’s procedures for approving funding applications and spending plans.
In practice, this means that the Trustees ensure that all funding applications and spending plans contain clear, identifiable public benefits that meet the strategic goals and charitable Objects of Leeds Hospitals Charity and support NHS charitable purposes relating to Leeds Teaching Hospitals NHS Trust and its patients.
The Trustees compare each funded project’s achievements and outcomes against the strategic goals and activities of Leeds Teaching Hospitals NHS Trust in order to review the benefits brought to the public.
Louis, pictured, is part of Unity - The After Cure Choir for survivors of childhood cancer, which is supported by Leeds Hospitals Charity.
Annual report and financial statements 2022/23
9
Contents
**Grant funding** The main way in which Leeds Hospitals Charity meets its Objects and strategic goals is through projects funded **£0.7m** under each of our six priority areas. **Equipment** 49 applications In 2022/23, we awarded a total of £13.2m across those six funding priorities through 281 funding applications. This represents the largest grant funding expenditure since the Charity became independent. **Environment £7.1m** 27 applications Included in the £13.2m are two significant grants: one a commitment of £6.8m to fund the building of the Rob Burrow Centre for Motor Neurone Disease, a new care centre for patients and their families; the other an investment of £2.6m to fund the Child Health Outcomes in Leeds (CHORAL) **Research and innovation £4.3m** programme, an infrastructure research programme bringing 48 applications **£13.2m** together clinicians, researchers, academics, patients and their families. We also continued to fund a range of projects ~~5~~ of varying size and complexity, recognising the significant impact small amounts of charitable funding can have on the **281 funding** health and wellbeing of beneficiaries alongside those **Health and wellbeing £0.8m** larger investments. 57 applications **applications** A focus of 2022/23 has been building relationships with potential applicants, which we’ve done in several ways: through engagement activity; by ensuring equity of **£0.16m** opportunity; by streamlining our processes; and through **Specialist staff** 5 specialist roles understanding and sharing our impact with supporters and stakeholders. We encouraged applicants to consider how their proposals align with our three key impact areas: tackling health inequalities, innovation and health technologies and treatments for rare diseases. More about our achievements **Education £0.16m** in these areas can be found in section 7 of this report on 95 applications page 22. Leeds Hospitals Charity is a member of the Association of Medical Research Charities and all research and innovation grant funding is awarded in line with its policies and principles. The committee structure for awarding grant funding is set out in section 14. Contents 10
**Grant funding**
Annual report and financial statements 2022/23
5 **£0.7m Equipment 49 applications**
Our charitable funding enabled Leeds Teaching Hospitals NHS Trust to purchase equipment that will ensure it leads the way in health technologies and innovation.
Significant investments in cutting-edge technology like a carbon dioxide laser for robot-assisted surgery and the CONVIVO® digital biopsy tool, which allows for real-time review of tumour biopsies, will be lifealtering for those dealing with serious diagnoses. But smaller items can make a huge difference too.
This year we’ve funded electric breast pumps for the Cleft Lip and Palate Service, a Sara Stedy sit-tostand aid and MOTOmed movement therapy bike for complex rehabilitation at Chapel Allerton Hospital, PATSLIDES with additional functionality for use on orthopaedic wards and a portable slit lamp for the Ophthalmology team – all of which are already having a positive impact on patients in Leeds.
## **CO2 laser**
The Head and Neck specialist team at Leeds Teaching Hospitals NHS Trust currently sees around 145 patients with complex conditions who are waiting for life-changing surgery. Patients like Victoria, 51, from Holmfirth, who was told that the best option to treat her tracheal stenosis, a condition in which scar tissue narrows the airway, was a tracheostomy.
Victoria’s condition had been deteriorating for over ten years, so she was resigned to undergoing this major operation. Thankfully, the arrival of a carbon dioxide laser, purchased with our funding, offered a less invasive alternative.
Victoria became one of the first patients to benefit from this new technology, with surgeons able to precisely remove thin layers of skin with minimal damage to the surrounding areas.
“This laser has given me a lifeline,” says Victoria. “Now, I feel like myself again. I can get a good night’s sleep without panicking that I can’t breathe, and I can go out and enjoy life with family and friends without feeling like a burden.”
On average, the team will use the new laser to treat around ten oropharyngeal and laryngeal cancer patients per month, with the potential to expand to other conditions.
“This brand-new laser allows surgeons to perform head and neck surgery in new ways, ensuring Leeds has the opportunity to become a world leader at robotic surgery,” explains Melissa Hepworth, Head and Neck Service Manager. “We hope that this will unlock opportunities for other Ear, Nose and Throat subspecialities to use laser technology for their procedures and help achieve better outcomes for more patients.”
**“**
This brand-new laser allows surgeons to perform head and neck surgery in new ways, ensuring Leeds has the opportunity to become a world leader at robotic surgery.
**Melissa Hepworth, Head and Neck Service Manager**
Annual report and financial statements 2022/23
11
Contents
## **£7.1m 27 applications** 5 **4+**
**£7.1m Environment 27 applications**
In 2022/23, we awarded just under 54% of our grant funding expenditure to environmental projects. From refurbishing rooms for relatives visiting loved ones in intensive care to providing fish tanks for paediatric wards and wall art depicting the cancer treatment journey, our focus always is improving the medical environment for patients and their families.
The largest grant we awarded was to fund the building of the Rob Burrow Centre for Motor Neurone Disease, a new care centre for patients at Seacroft Hospital. The centre will provide a calm, welcoming space for patients and their families to access clinical and holistic care, and we are working closely with Leeds Teaching Hospitals NHS Trust to fundraise and plan for this unique project’s completion.
Elsewhere, another long-term funding project reached its conclusion this year. Kickstarted back in 2017 with a successful £2.4m appeal, the much-anticipated MR Sim (magnetic resonance imaging in radiotherapy for the purposes of simulation) was installed in March 2022 and will transform the way radiotherapy treatment is delivered to thousands of patients every year. In 2022/23, we awarded additional funding for nature-themed wall art for the MR Sim clinical rooms to create a calming and welcoming environment for patients.
## **Dementia-friendly wards**
navigate the ward, and large day/night flip calendar clocks to help patients orientate themselves with the date and time of year.
Between July 2020 and June 2021, 4,888 patients with dementia were admitted to the Older People’s Wards at Leeds Teaching Hospitals NHS Trust.
Taking part in activities can help people feel better and improve wellbeing, encourage much needed social stimulation, reduce boredom and help patients maintain their independence.
**“**
“These changes to the environment will make a huge difference. The wards will feel more welcoming and friendly, helping to reduce stress and agitation,” says Ali Raycraft, Lead Nurse for Older People.
A busy hospital environment can be distressing for those with dementia, something the Trust is hoping to tackle using our funding. Installing ‘sky inside’ ceiling lights that can be programmed to show clouds passing or tree branches moving in the wind will bring the outside in, creating calm surroundings. There will also be murals of familiar Yorkshire locations in the corridors and new artwork above beds to give patients ‘landmarks’ to
**Ali Raycraft, Lead Nurse for Older People**
The funding has also helped to purchase dementia-friendly activity materials such as colouring books, puzzles, jigsaws, playing cards, dominoes and table tennis for patients to enjoy with staff or relatives.
Annual report and financial statements 2022/23
12
Contents
**£4.3m Research 48 applications and innovation** 32
In 2022/23, 33% of our total grant funding was awarded to research and innovation at Leeds Teaching Hospitals NHS Trust, with the potential to reach an astounding 1.83m people.
We’ve made significant investment in research into child health this year, most notably the Children’s Health Outcomes Research at Leeds (CHORAL) programme and the National Institute of Health and Care Research’s INSCHOOL study. Other areas supported include stroke, barriers to kidney transplantation, liver perfusion, microbial resistance, immunotherapy, end-of-life care for patients with heart disease and treatments for patients with cancer, including the use of artificial intelligence in detection and oral health care during chemotherapy. Funding for publications and conference attendance, meanwhile, provided opportunities for researchers to share their research outcomes and keep abreast of trials.
This year also saw a number of previously - funded research projects reach conclusion with positive outcomes for patients in Leeds, including studies of melanoma and brain tumour immune response. This is precisely why we’re so passionate about funding research and innovation in particular – because data shows that research-active hospitals ultimately deliver better patient care.
## **CHORAL Children’s Health Outcomes Research at Leeds**
**£5.5m**
investment partnership
In March 2023, Leeds Children’s Hospital and the University of Leeds announced the launch of the CHORAL Research Centre.
Delivered over five years, CHORAL will be the biggest research programme ever undertaken by the hospital and it’s taken a £5.5m investment partnership to get this vital project up and running: £0.5m from Leeds Teaching Hospitals NHS Trust and £2.4m from the University of Leeds, with the final £2.6m provided by Leeds Hospitals Charity.
I am incredibly excited to launch the CHORAL research programme here in Leeds. This is a fantastic opportunity to establish a world-leading research centre in the city, led by Leeds Children’s Hospital. Through a clear focus on child health, the CHORAL team will deliver truly transformative research to improve the lives of future generations of children in Leeds.
**“**
**Professor Adam Glaser, Director of the CHORAL Research Centre**
Annual report and financial statements 2022/23
13
Contents
## **INSCHOOL school**
The five-year INSCHOOL study explores the impact on school life faced by children and young people with long-term health conditions. We’ve provided additional funding to recruit a research fellow who will talk to parents and guardians about their experiences and the challenges their child faces, as well as issues around securing support from school on behalf of their child.
## **“**
The young people who have taken part in the qualitative project, and those who have helped us with the research, have all been amazing. […] we have had fantastic support from staff at Leeds Children’s Hospital and other professionals across the region to help make our research the best it can be. We will continue to work hard to use this collection of stories to influence policies to support young people with their school lives in the future.
**Dr Simon Pini, Senior Clinical Research Fellow**
## **Paediatric research fellowship**
In September 2022, trainee doctor Kate Parmenter joined the Paediatric Clinical Research Facility on a year-long clinical research fellowship funded by Leeds Hospitals Charity.
There are currently over 100 active clinical research studies ongoing at the research facility, with more than 1,000 babies, children and young people involved in 2017/18, and Kate has already worked on a variety of projects with the aim of improving personalised care for young people. Her vision is that every child, if eligible, should have the chance to be part of a clinical trial.
“I believe that every young person should have the opportunity to be part of research regardless of their family’s socioeconomic background,” explains Kate. “Over the past few months there has been an increase in the number of babies, children and young people involved in research trials and we’ve now recruited a larger proportion of patients, which is a hugely positive step forward.”
In order to achieve her vision, Kate’s made it a priority to educate her peers on the importance of researchled care and treatment: “A huge part of my role has been an education piece for my colleagues. Many parents don’t realise there are opportunities for their child to be part of research trials, so it’s our job to approach them for consent, which many doctors find a difficult conversation to broach.”
Kate’s ambitious plans for the rest of her fellowship also include addressing health inequalities for children across the region and recruiting children with rare conditions to more research trials.
## **Brain tumour research**
A feasibility research study establishes whether something can and should be done, paving the way for a larger, more definitive piece of work. This year we supported a small feasibility study into methods to detect and identify white blood cells in brain tumour tissue.
“We were successful in applying the method tested in blood to brain tumour tissue and showed that from five brain tumour tissues we were able to extract white blood cells. Identifying the types of cells showed that the tissues contained lymphocytes (predominately T cells) and granulocytes.
## **“**
Based on this small study,
we were able to successfully develop a method for use in future research [...] with the longterm aim of helping to identify potential treatment targets and/ or biomarkers of prognosis/ progression.
## **Paul Chumas, Principal Investigator**
## **Melanoma research**
Melanoma is a skin cancer which is becoming increasingly common. Research we’ve funded has shown that vitamin D plays a role in whether patients die of their melanoma. It also revealed the harmful effect of systemic inflammation.
“Recruitment started in 2012 and continued until 2016. In the period since 2016, we completed the collection of follow-up data which relates to relapse from cancer, death and cause of death, and treatments postdiagnosis for melanoma. The data set was closed in January 2022. In all, 393 melanoma patients consented to participate. The nature of our work is that we build up very large, long-term cohort studies in which we collect epidemiological and medical data as well as samples. This takes many years, but results in unique resources.” Julia Newton Bishop, Principal Investigator
## **“**
The Leeds Hospitals Charity grant allowed us to generate a complete data set which will be used by us and hopefully others in the years to come.
## **Julia Newton Bishop, Principal Investigator**
Annual report and financial statements 2022/23
14
Contents
6 **£0.8m Health and 57 applications wellbeing**
With the after-effects of Covid-19 still being felt and a cost-of-living crisis ongoing, 2022/23 was a tough year for many.
As in previous years, we did what we could to help – 6% of our total grant funding went towards supporting a wide range of projects and activities to improve the health and wellbeing of patients and their families, as well as hardworking NHS staff.
We continued to fund a scheme established during the pandemic which allows patients and volunteers across all hospital sites to apply for small grants of up to £500 to alleviate financial hardship caused by prolonged hospital stays. Other health and wellbeing initiatives included supporting staff who are observing Ramadan by offering water and dates to eat when it came time to break their fast; designing memorial events and books; donating clothes for patients who need them; supplying memory making materials for patients across all our hospitals; funding resources for the play therapists at Leeds Children’s Hospital; and providing hearts and crosses for hospital chaplains to give to end-of-life patients and their loved ones.
It’s often these small gestures that mean the most to patients and their families, and we’re happy to be part of improving their hospital experience wherever we can.
## **Christmas comforts**
A hospital stay over the holiday period can be tough for patients, so we were delighted to help supply some cheer.
In Leeds Children’s Hospital decorations were hung and stars lit up Clarendon Wing as part of the Christmas Sparkle campaign, while visits from Santa and his reindeer brought festive fun. Charitable funding also provided every inpatient with a gift on Christmas day and ‘thank you’ hampers for all staff. Those working on Christmas day were treated to Christmas breakfast and/or dinner.
We bought all our patients **“** a fleece blanket, as the ward gets a little chilly on a night. The patients all loved them and were so happy to have a present to open on Christmas morning. **Hayleigh, Ward Manager, Stroke Rehabilitation Unit** Thank you for the funding **“** offered for the patients that spend Christmas in hospital. **Mina, Ward Manager, J32**
**----- Start of picture text -----**
Memory making materials
**----- End of picture text -----**
Samantha Oakes is a family support worker based at Seacroft Hospital, providing a listening ear, practical guidance and emotional support to patients with motor neurone disease (MND) and their families.
“The memory making kits have been an invaluable resource and the funding has had a massive impact on patients and their families experience while going through an incredibly difficult time,” says Samantha. “Patients often tell us that they have wanted to start memory making activities with their loves ones but didn’t know how, and having this available at the centre has helped give them some peace of mind.”
Samantha applied for funding from Leeds Hospitals Charity to support pre- and postbereavement care for children and adults. She purchased supplies for memory making kits – boxes that can contain handprints, locks of hair and pocket hugs – and books about anticipatory grief to helping families navigate the bereavement process. The aim is to offer a less daunting way to discuss and prepare for death, encouraging loved ones to interview the person with MND and create lasting memories.
The MND Clinic can be long in duration and emotionally and physically tiring for patients and their families, so funding was used to supply refreshments such as tea, coffee, biscuits and soups to help everyone feel more at home. Samantha also purchased jigsaws and games to offer in clinic or to take home.
Annual report and financial statements 2022/23
15
Contents
1 **£0.16m Specialist 5 specialist roles staff**
In 2022/23, we continued to provide vital funding for specialist staff roles – 1% of total grants awarded.
The NHS couldn’t function without its hardworking staff, and we want Leeds Teaching Hospitals NHS Trust to have the very best, whether that’s the bereavement nurse whose funding we’ve provided for the second year running or the ocular prosthetist who’s joined Leeds Artificial Eye Service. We’re excited to watch these roles develop and fulfil their potential to enhance the patient and family experience.
## **Virtual reality play specialist £75k**
to create a new role a Virtual Reality Play Specialist
Being in hospital can cause a lot of anxiety for children and young people and be a stressful time for all the family, something the Play Therapy team at Leeds Children’s Hospital is always looking to alleviate.
A six-month research project exploring new ways to improve young patients’ experience tested out the impact of using a VR headset during treatment. The results found that 91% of children who used the VR headset for the whole treatment said it made treatment better, helping them feel happier and more relaxed.
A hospital environment can be a daunting place for a child or young person, so using a VR headset helps reduce their anxiety and stress, improving the hospital experience for children and their families.
**“**
As a result, the Play Therapy team applied to us for a funding boost of £75k to create a new role – Virtual Reality Play Specialist – to support children and young people across Leeds Children’s Hospital using this new technology. With the specialist’s guidance, patients will be able to explore alternate surroundings and play games to keep them calm during all kinds of procedures, while families can be reassured knowing that their loved one’s pain and worry is reduced.
**Lucy Dove, Virtual Reality Play Specialist at Leeds Children’s Hospital**
“This funding will enable more children and young people to benefit from this service, helping to reduce the number of general anaesthetics for minor operations and procedures, which can reduce a child’s time spent in hospital,” explains Virtual Reality Play Specialist Lucy Dove.
Annual report and financial statements 2022/23
16
Contents
1 **£0.16m Education 95 applications** Conference attendance will **“** enable us to gain up-to-date insight into neuromodulation research that is being undertaken in clinical settings. This will present the team with significant learning opportunities, enhancing their skills and knowledge and contributing to their professional development. **“** [It] will also facilitate the forging of new connections, expanding the team’s network and identifying new collaborators with whom new research projects can be started.
## **Eva Moynihan Prize**
The University of Leeds Eva Moynihan Prize recognises outstanding performance and commitment and is awarded annually to a final year nursing student with our funding. This year’s award and £500 cash prize went to Tia Hau, who by happy coincidence is also a Leeds Hospitals Charity fundraiser!
Getting the right person for the job is extremely important, but providing the right training can be essential. In 2022/23, we continued to fund education and training for staff across Leeds Teaching Hospitals NHS Trust, dedicating 1% of our total grant funding to the task.
The opportunities we’ve funded enable staff to continually grow and develop, and in doing so enhance their skills and knowledge to provide better patient care. Alongside courses, qualifications and organisational-level awareness activities, a particular highlight has been the Neonatal Unit applying for UNICEF accreditation. Staff are regularly supported to disseminate learning at conferences, and knowledge has also been passed on to patients and families through educational events such as the one for people with paroxysmal nocturnal haemoglobinuria.
For the past three years I have studied Children’s Nursing at the University of Leeds, during which I had many placements at Leeds Children’s Hospital. While at university, I was a Committee member for the nursing society and last summer we organised a ball and managed to donate most of our profits to Leeds Hospitals Charity.
Time out to reflect and learn also has the potential to boost morale and ensure Leeds Teaching Hospitals is able to retain talented and experienced staff. Activities to support this have included reset days for multidisciplinary teams and away days for many others, providing vital opportunities to reconnect after the stress of the pandemic.
**Beatrice Bretherton, Pain team**
**Tia Hau**
Annual report and financial statements 2022/23
17
Contents
## **Our linked charities**
Leeds Hospitals Charity currently has 12 linked charities registered with the Charity Commission.
To ensure robust governance arrangements are in place for our linked charities, we have embedded a linked charity framework which includes an annual partnership panel meeting and submission of an annual report by linked charity representatives. Linked charities are supported by all directorates (Fundraising, Communications, Governance and Finance and Corporate Services) and we work in close partnership with their representatives to achieve the Objects of each linked charity.
**----- Start of picture text -----**
Governing
document
Charity scheme
Name Purpose number dated
To further any charitable purpose or purposes relating to the general or any specific purposes
Leeds Teaching Hospitals Charitable
of the Leeds Teaching Hospitals National Health Service Trust or the purposes of the National 1170369-1 29 March 2017
Fund
Health Service
Leeds Chest Clinic General Purpose For any charitable purpose or purposes relating to the National Health Service and in particular,
1170369-2 29 March 2017
Charity but without any limitation, for the services provided by the Leeds Chest Clinic
29 March 2017;
Arthritis and Inflammatory Diseases
For any charitable purpose or purposes relating to the rheumatology and arthritis services
1170369-3 amended
Charity (formerly the Inflammation
at Leeds Teaching Hospitals within the National Health Service
Group Fund) 27 June 2023
29 March 2017;
To enhance the care and treatment of children in Leeds Children’s Hospital and to provide
Leeds Children’s Hospital Charity 1170369-5 amended
equipment for Leeds Children’s Hospital
24 April 2018
Sir Robert Ogden Macmillan Centre To support the Sir Robert Ogden Macmillan Centre 1170369-6 29 March 2017
Yorkshire Brain Appeal To fund research and clinical trials into brain diseases 1170369-7 29 March 2017
29 March 2017;
To fund specialist medical equipment for diagnosis and treatment of cancer; to fund cancer
Leeds Cancer Centre Charity 1170369-8 amended
research; and to enhance the care of patients with cancer
24 April 2018
To fund research into breast cancer and the purchase of equipment for the treatment
Breast Cancer Research Action Group 1170369-9 29 March 2017
of breast cancer
Leeds Children’s Transplant Team 29 March 2017
(formerly Leeds Little Livers – To support child transplant patients to participate in Transplant Games and events 1170369-10 amended
Transplant Games Trust Fund) 27 June 2023
Rays of Hope To fund and support research into cancer conditions of the liver 1170369-11 29 March 2017
The income shall be applied for the purchase of medical equipment or to further medical research
(but excluding research relating to the transplantation of human organs, human egg cells or human
Elsie May Sykes 1170369-12 29 March 2017
embryos and excluding medical research involving the vivisection of animals) for
which no exchequer funds are available for the benefit of the hospitals
For the purpose of paediatric oncology research and/or at the absolute discretion of the Trustees for
Jeremy Neil Allen paediatric services (including research) and/or for any other part of Leeds Teaching Hospitals within 1170369-13 29 March 2017
the National Health Service for the purpose of paediatrics and/or oncology (including research)
**----- End of picture text -----**
Annual report and financial statements 2022/23
18
Contents
## **Rays of Hope**
Rays of Hope is dedicated to raising funds for research into cancer conditions of the liver. Following a submission to the Charity Commission, approved by the Board of Trustees, it has been proposed that Rays of Hope’s charitable Objects are: “To support research and education related to both emergency and elective surgery, hepatopancreato-biliary surgery for cancer and other harmful conditions, and abdominal organ transplantation in order to improve patient care and outcomes.”
The charity’s funded activities in 2022/23 included conference attendance by researchers and the wider clinical team, as well as the continuation of the ‘Analysis of biomarkers for prediction of posttransplant function of abdominal organs’ study. Key research activities included designing and perfecting the ex-vivo perfusion model; identifying the most robust method for flavin mononucleotide (FMN) biomarker detection in both tissue and serum; completing the collection of short preservation samples (tissue and serum); and designing the hypothermic machine perfusion model for the pilot study.
## **“**
It is hoped that this research will help to better predict the longevity of transplanted organs in individuals, giving patients the best possible chance at life post-transplant.
**Paul Williams, Research Fellow**
## **Arthritis and Inflammatory Diseases Charity**
The Arthritis and Inflammatory Diseases Charity supports the rheumatology and arthritis services at Leeds Teaching Hospitals, which have an international reputation for the investigation and management of rheumatic and musculoskeletal diseases.
As a centre of excellence, Leeds is at the forefront of world-leading research, including studies which have shown that patients with conditions like rheumatoid arthritis can be identified via immune abnormalities several years before diagnosis, because of protein found in their blood.
In response, Professor Paul Emery and the team at Chapel Allerton Hospital have developed a referral network of 500 people who are at risk of developing arthritis, which will give them quicker access to treatment if required. Patients will trial drug therapies and non-invasive conservative treatments such as dental hygiene, smoking cessation and dietary manipulation to help reduce their risk of developing the condition.
## **“**
The funding from Leeds Hospitals Charity has been a real stepping-stone for us, it has allowed us to shift our focus from early diagnosis of conditions like rheumatoid arthritis to exploring preventative measures.
**Kulveer Mankia, Clinical Associate Professor and Honorary Consultant Rheumatologist**
Leeds Hospitals Charity proudly supported the Leeds Children's Transplant Team in the 2022 British Transplant Games.
## **Leeds Children’s Transplant Team**
Four-year old Otis was born with biliary atresia, which causes scarring of the liver, and required a liver transplant at 3 months old. Otis took part in the 100 Days Fundraising Challenge in the run up to his first-ever Games this year, completing 1km on his bike.
Leeds Children’s Transplant Team is dedicated to supporting children and young people to participate in the annual British Transplant Games, which the Leeds Children’s Hospital transplant team attends for four days every summer.
## **“**
Held in Leeds itself in 2022, transplant teams from across the country were able to enjoy a range of activities and sports, take part in the donor run and spend time together as a community. The games provide a unique opportunity for patients and their families to meet others who have experienced a similar journey, celebrate life after a transplant and remember donor families.
For the first couple of years of his life, Otis went through an incredibly tough time, and then COVID hit, so he hasn’t had the chance to be part of the Leeds Children’s transplant team. Otis is now at an age where he is starting to understand a bit more about his transplant, the Games and why he’s fundraising for charity.
The success of Team Leeds in Britain meant they qualified for the World Transplant Games in Australia in spring 2023, and the charity was delighted to help fund the costs of those from Leeds who participated.
**Jon, Otis’ dad**
Annual report and financial statements 2022/23
19
Contents
**----- Start of picture text -----**
Leeds Hospitals Charity has funded a series of research
trials into MS (Multiple Sclerosis) supported by Claire Reidy,
Specialist Nurse in the Neurology Research Team.
**----- End of picture text -----**
## **Yorkshire Brain Appeal**
A team led by Professor Helen Ford continues to deliver on the Yorkshire Brain Appeal’s purpose: conducting research studies into brain disease and ensuring patients in Leeds have access to clinical trials.
In 2022/23, further funding was provided to appoint a brain research nurse with a focus on three multi-centre multiple sclerosis (MS) trials. In addition, Clinical Fellow Dr Linford Fernandes concluded a pilot study with 42 progressive MS patients, that commenced in 2019, looking into how different treatments and drugs affect hand mobility.
This is the first study of its kind, and its results will need to be replicated in future studies, but it shows that hand function is severely affected in many people with progressive MS and this is not always related to mobility. While there will be no change to the clinical care of the patients in the study as a direct result of its findings, the data Dr Fernandes has obtained will help clinicians to develop effective and accurate ways of monitoring hand function. The aim is to make this part of routine clinical care, especially for people who report difficulties with hand function. The study has also provided valuable insights into how motion capture can be used to analyse and monitor hand function.
**----- Start of picture text -----**
Leeds Hospitals Charity provided funding which enabled Leeds Cancer Support to provide free wigs for patients
undergoing cancer treatment.
**----- End of picture text -----**
## **Sir Robert Ogden Macmillan Centre**
Leeds Cancer Support (located within the Sir Robert Ogden Macmillan Centre) complements clinical care by offering information and a wide range of holistic support in a warm and welcoming environment. The centre’s services are available to anyone who has been affected by cancer: both patients and those supporting them. The centre benefits from specialist staff and trained volunteers who run services and meet patients and their carers.
Over the last year, charitable funding has continued to fund the provision of the hair loss service, which offers practical and emotional support for people experiencing hair loss due to cancer treatments. Previously, clients would have to pay prescription charges for their wigs, with a cost of around £78.15, meaning some patients didn’t take up the offer of a wig, even though they would have liked to. Our funding has enabled Leeds Cancer Support to open up the service to every patient, regardless of their ability to pay.
Annual report and financial statements 2022/23
20
Contents
## **Breast Cancer Action Research Group**
Breast Cancer Research Action Group was formed in 1994 by ex-breast cancer patients and their supporters. The group fundraises to support breast cancer research and supply equipment in Leeds and its aim was to campaign for a dedicated breast unit at Leeds General Infirmary. Since its inception, the group has raised enough funds for a new breast unit at St James’s Hospital, dedicated research fellows and equipment. The linked charity remains proactive and continues fundraising for specific projects.
In October 2021, Leeds Hospitals Charity launched a funding call for a range of research posts using money raised by Breast Cancer Research Action Group. We subsequently approved two project grants in May and August 2022 respectively:
Improving breast cancer responses to chemotherapy through chemosensitisation strategies (£50k) – Breast cancer patients at high risk of recurrence are offered cytotoxic chemotherapy as part of their treatment. Unfortunately, this therapy is not always successful, and patients often still face recurrence, usually terminal. Therefore, there is an urgent need to make cytotoxic chemotherapy work better. We have recently discovered that some breast cancers resist chemotherapy by reducing their levels of two particular proteins: ITGA7 and SEMA6D. This project will reactivate these proteins in breast cancer cells in order to stop their resistance to chemotherapy, investigate which breast cancer types this therapy might apply to and work out how best to use this new therapeutic strategy as an enhancement to chemotherapy. The eventual aim is to use this as a combination therapy with chemotherapy to improve outcomes for patients.
- Clinical benefit and cost impact of automated breast image quality assessment to support system efficiencies (£30k) – This project is looking at whether we can use an automated process to assess the quality of the mammograms (breast X-rays) taken when women attend breast screening. A good quality image is important to help the doctor identify if cancer is present on the mammogram and means that fewer women will have to return to have a repeat mammogram because the first was not acceptable. Currently the quality assessment process is manual and time-consuming and so is performed at a later date. An automated process would enable the quality assessment to happen at the time the mammogram is taken, generating a report for the radiographer that can be used in education and tailored training supported by the quality lead. The project aims to evaluate what using this automated tool instead of the current processes means in terms of cost savings.
**----- Start of picture text -----**
Dr Nisha Sharma is a member of several national breast screening committees and is driving innovation at Leeds Teaching
Hospital with the support of Leeds Hospitals Charity.
**----- End of picture text -----**
Annual report and financial statements 2022/23
21
Contents
**7 Achievements and performance – supporting our hospitals, impact areas** As part of our five-year strategy, we **Distribution of expenditure and** £947k continue to prioritise grant applications **application across each key impact** that can demonstrate benefits in one **area in 2022/23** of three key impact areas: £3.79m **1. Tackling health inequalities Total applications by impact area** Paediatric care 49 36 Cancer care Mental health care 10 **Funding value** Transplantation 16 Cardiovascular care 9 2£653k Care of older people 8 **£13.2m** End-of-life care 13 £287k **Health technologies 2.** 25 **and innovation** £115k **3. Rare diseases** 29 £6.94m 86 (other) £78k £79k £113k £158k
Annual report and financial statements 2022/23
22
Contents
## **Tackling health inequalities**
There are currently 455 people waiting for a kidney transplant at Leeds Teaching Hospitals NHS Trust. Among them is Min Minhaj, 48, who has been on the list for over three years.
For Min, everything is on hold until a donor is found: “I lost all my freedom after I was diagnosed. My life has turned into one endless hospital appointment. I can’t travel far because I need to be on hand for dialysis, and everything I eat and drink is monitored. I am scared that my dialysis might stop working, or my health will deteriorate, so I might not even be able to have a transplant when a match is found.”
Living donor kidney transplantation (LDKT) is the most effective way to help patients get back to normal life. Kidneys from a living donor can last up to 20 years, compared to just 10–12 years from a deceased donor, and recipients tend to live longer and have a better quality of life.
In the UK, 35% of kidney transplants are from living donors; however, this falls to 14% in ethnic minority patients, even though they make up over a third of the national transplant waiting list.
Leeds Hospitals Charity has funded groundbreaking research with patients at Leeds and Bradford renal units that aims to identify barriers to LDKT for people from black, Asian and minority ethnic (BAME) and lower socio-economic backgrounds.
“The initial review I undertook in February 2021 found that there were several barriers to LDKT in BAME communities,” explains Consultant Nephrologist Dr Sunil Kumar Daga, who is co-leading the research. “We saw that there was a lack of relevant knowledge, fears about the risks of transplantation for the donor, as well as religious, cultural and financial concerns. This made me realise we need to do more to raise awareness and tailor resources and support we offer to patients and their families to reassure them that a living kidney transplant would give the best quality of life.”
The team plans to develop comprehensive resources to support patients’ decisionmaking. It is hoped that this will help reduce the inequalities in access for people from underserved groups.
Min Minhaj is waiting for a Kidney Transplant and is part of a group of patients who will benefit from research funded by Leeds Hospitals Charity.
Annual report and financial statements 2022/23
23
Contents
## **Health technologies and innovation**
The Neurology team at Leeds Teaching Hospitals NHS Trust treats patients with a range of neurological conditions, including cancerous, non-cancerous and benign brain tumours, which can be life-threatening if left untouched.
Previously, tumour samples requiring a biopsy had to be transported to a laboratory at a different hospital for analysis – a time-consuming process, especially since results sometimes came back as inconclusive.
This year, Leeds Hospitals Charity invested £150k to fund the purchase of a ZEISS CONVIVO Pathology Suite, state-of-the-art equipment that produces high-quality images of tumours in real time so pathologists can make a quicker and more accurate diagnosis during surgery.
The innovative technology will have huge benefits for patients, as Honorary Consultant Neurosurgeon Ryan Mathew explains: “We are so grateful that Leeds is the first hospital in the UK to benefit from this revolutionary technology, which allows us to work more accurately and efficiently and in turn reduce risks to patients, so they can recover much quicker, with as little disruption to their life as possible.”
The CONVIVO also enables surgeons to remove as much of the tumour as possible with minimal damage to healthy cells surrounding it.
The first patient in Leeds to benefit from surgery using the new suite was 34-year-old Nathan James.
“I had a seizure at home and woke up at the Leeds General Infirmary, where I had a scan which showed a 3cm mass on my brain,” recalls Nathan. “I stayed in hospital for around three days while I recovered. Surgery to remove the benign tumour was arranged using a procedure with the new technology. “I like that I’m the first person in the UK to be accessing this procedure and am happy to be a pioneer for this technology. I am pleased that I’m supporting other people to access better treatment.”
## **Rare diseases**
In 2022/23, the charity has provided over £90k of funding in support of patients with cystic fibrosis, an inherited, lifelimiting condition which causes sticky mucus to build up in the . lungs and digestive system
The initiatives we’ve funded will make a real difference to the quality of life enjoyed by people living with cystic fibrosis in Leeds. Most significant is revolutionary drug research that could potentially find a cure for the condition within the next ten years; however, we’ve also invested in projects that will make patients more comfortable right now, including the refurbishment of the patient kitchen on the Cystic Fibrosis Unit and the provision of activities and extra facilities to help make patients feel more at home during treatment.
Michelle, 43, has been being treated at Leeds Teaching Hospitals NHS Trust since she was just 16 years old, so she’s well placed to give feedback on the positive impact of these changes for patients.
“Over the past six months I’ve spent eight weeks in hospital, so I’ve seen first-hand how charitable donations are making a huge impact,” says Michelle. “When I’m in isolation away from my husband and daughter, it can be an incredibly lonely time. The little home comforts really do make a difference, like having a comfy chair to relax in and access to TV and entertainment. I’ve yet to use the sparkling new kitchen facilities, but I will certainly take advantage during my next admission.”
Professor Daniel Peckham, Director of the Leeds adult Cystic Fibrosis Unit where Leeds Hospitals Charity are supporting research and investing in projects to help make patients like Michelle and Rachel (pictured) feel more comfortable.
Annual report and financial statements 2022/23
24
Contents
## **Supporting staff**
Recognising the impact that the legacy of the Covid-19 pandemic continues to have on our hospitals, we have worked with Leeds Teaching Hospitals NHS Trust to offer support to staff, providing almost £0.5m towards projects specifically for NHS employees.
A priority has been ensuring the continuation of the Employee Support Fund, which enables staff who are experiencing financial hardship to apply for small grants up to £500. The fund has allocated over 200 grants and awarded nearly £0.1m in financial support for staff over the last year.
We’ve also provided funding for the renovation of staff rooms and wellbeing spaces to give hospital staff the best possible environment to work in, and supported the annual staff ‘Time to Shine’ awards to make sure they know how are valued they are. ‘Little extras’ include ‘thank you’ hampers at Christmas, breakfast or dinner for those working on Christmas Day and subsidised taxis during the festive season.
## **Ongoing impact of funding**
Every year, Leeds Hospitals Charity supports Leeds Teaching Hospitals NHS Trust with funding for their Chief Nurse Education fund, which helps nurses, midwives and allied health professionals with the costs of training and qualifications.
Midwife Josie Lutchman was awarded a grant from the Chief Nurse Education Fund this year to support her training to become a Birth Trauma Resolution Practitioner.
“Trauma can be experienced before, during or even after birth,” explains Josie. “Currently, if a patient has a traumatic experience, they are offered a debrief with our team to understand why certain things have happened. I hope with the training from this course we will develop this further and support patients and their families to resolve this trauma, hopefully improving patient experiences for more positive outcomes.”
Josie plans to pass on what she’s learned in the hope of creating a service where trauma-informed care is a priority for all: “It will be fantastic to provide midwifery-led trauma therapy as a service to our patients in Leeds. The teachings could also provide support to our staff, offering a wellbeing service specific to maternity for any of our staff members who have been involved with a traumatic experience.”
**“**
I hope with the training from this course we will develop this further and support patients and their families to resolve this trauma, hopefully improving patient experiences for more positive outcomes.
**Josie Lutchman, Midwife at Leeds Teaching Hospitals NHS Trust**
Feedback from a client Josie has been supporting as part of her training shows just how vital such care can be: “After really struggling with the anxiety associated with the birth of my son, I found this a really comforting experience. Josie was amazing and has managed in three sessions to turn a lot of my negative experiences into a distant memory. I’m now due my second baby and looking forward to the birth. Life-changing experience!”
Annual report and financial statements 2022/23
25
Contents
## **8**
## **Feedback from our NHS staff**
Funding from Leeds Hospital Charity has helped to provide family accommodation at Eckersley House, alongside practical and emotional support for families with seriously ill children being treated at Leeds Children’s Hospital. Between April 2022 and August 2022, 113 families received accommodation. Our longest stay was 254 days whose child is awaiting a heart transplant.
The charity has helped to supply babies and families on the neonatal unit with Zaky HUG hands hands, which can be moulded to cradle neonates in a position that mimics the one they would be in if they were still in their mother’s womb.
Thank you - the warming blanket has made a huge difference in keeping patients who require radiotherapy under anaesthetic warm during treatment and in recovery, aiding better rehabilitation.
So grateful for the support and funding but also feel that we are valued by the charity as an area that benefits from the funding. The refurbishment of St James’s University Hospital’s Chapel of Rest has improved the environment to make it more respectful, peaceful, pleasant and calm.
Due to Covid-19 restrictions, some of our patients who were in hospital on Christmas day would only have received limited physical contact from family, friends and relatives. Being able to give a gift to patients at Christmas was a lovely way of lifting their spirits. We are really grateful to Leeds Hospital Charity for being able to support us with this initiative.
Thank you for all your support over many years! We have invested in two state-of-the-art incubators for our smallest patients. It’s so important for our babies to stay warm and away from infections, so having modern equipment that enables that is essential in us delivering the best clinical care that we can.
Annual report and financial statements 2022/23
26
Contents
## **Fundraising**
## **Our fundraising promise**
We are incredibly grateful to the donors and fundraisers who support a wide range of causes across Leeds Teaching Hospitals NHS Trust. They are our greatest strength and, as such, we treat them with care, respect and honesty, prioritising their needs and wellbeing at all times.
Our fundraising promise aligns with the Code of Fundraising Practice and is driven by the Charity’s values of transparency, transformation and working together. It can be found on our website to ensure supporters are aware of our commitment to them.
In 2022/23, professional fundraising agencies were engaged to assist with the promotion of both our lottery and regular giving campaigns.
Leeds Hospitals Charity believes everyone should be given the opportunity to support a cause they care about should they wish to; however, we recognise there are times when it is not appropriate to accept a donation, or where an individual may need extra time or support to make an informed decision about donating.
We are mindful of individual circumstances and make sure we provide individuals whom we believe to be vulnerable with the necessary time and support to make an informed choice about donating, including suggesting asking friends and family for advice. At any time, if we decide it is not appropriate to accept a donation, or if it came to light that a supporter who had already donated did not have the capacity to decide to donate, the donation would be refunded.
We provide guidance, information, support and training wherever possible to ensure our fundraisers and volunteers have a rewarding experience and carry out their fundraising activities in a way that is legal, open, honest and respectful.
Supporters fundraising ‘in aid’ of Leeds Hospitals Charity are encouraged to register with the Leeds Hospitals Charity Fundraising team, where they will be given guidance and asked to sign a fundraising agreement, where appropriate. A letter of authority is also issued.
Annual report and financial statements 2022/23
27
Contents
## **Our amazing supporters**
This year saw many in the community come together to raise funds for Leeds Hospitals Charity.
The Fundraising team felt truly privileged to hear from individuals, groups and businesses who wanted to show their continued appreciation of NHS staff during some of the toughest of years they’ve faced. This support was reflected by the charity welcoming 9,849 new supporters in 2022/23.
also won the solo category by arriving first in just 45 days!
## **The Atlantic Grappler**
Former Royal Marines commando Mike Bates has been supporting the Charity for many years now, inspired by the life-saving care his son Gabe received after being born prematurely and contracting meningitis.
Along the way, Mike has raised a staggering amount for the Charity: a gala ball at the Mansion in Roundhay brought in an amazing £35k during his training, with the rest coming from donations and sponsorship.
Mike’s fundraising efforts reached a crescendo this winter when he took on the world’s toughest row – the Talisker Atlantic Challenge – solo. After rowing more than 3,000 miles west from the Canary Islands to Antigua, Mike discovered that not only had he completed his challenge, but he’d
Mike’s donation has already been put to good use, paying for an application worth £65k for eight new high dependency unit (HDU) monitors for the Paediatric Intensive Care Unit in Leeds General Infirmary.
**The Norman Hunter Charity Golf Day**
In 2022/23, the friends and family of Leeds United legend Norman Hunter held their second annual charity golf day in his memory, with teams competing at Horsforth Golf Club, where Norman was a member for many years.
Both events were a huge success, providing great exposure for the charity and raising valuable funds for research into chronic lymphocytic leukaemia at the University of Leeds and St James’s University Hospital – £35k in 2021/2022 and £32k in 2022/2023.
The generosity of individuals and businesses across West Yorkshire in both monetary and raffle prize donations means that the Hunter family’s fundraising efforts have totalled over £0.1m over the last three years.
Annual report and financial statements 2022/23
28
Contents
Susan Wright pictured running the Leeds 10K with her daughter Katie who had run together since 2007 and raised over £40,000 for BCRAG
## **Breast Cancer Research Action Group**
Breast Cancer Research Action Group (BCRAG), one of our linked charities, has been an integral part of community fundraising for the past 20 years, bringing in a whopping £1.3m for breast cancer care. This incredible group of women raises awareness of primary and secondary breast cancer through sharing their lived experiences and has inspired Leeds Hospitals Charity supporters to donate with a range of fundraising and engagement events across Leeds.
Covid-19 impacted fundraising on an insurmountable scale, reducing not only people’s ability to donate but also to even meet to fundraise, yet BCRAG took it in their stride. In the two years affected by the pandemic, the group raised over £40k – a testament to the loyalty and dedication of their supporters.
Sadly, a few members have seen relapses in their treatment in 2022/23. Susan Wright, a valued and distinguished representative of the group, unfortunately died from breast cancer in April this year, having raised an astonishing £40k. She continued to fundraise after her diagnosis and inspired other breast cancer patients with her determination to support the Leeds Cancer Centre, where she was receiving treatment.
## **Jacqui’s Million**
Patient Jacqui Drake has continued her dedicated support of Leeds Hospitals Charity through her Jacqui’s Million appeal, raising much-needed funds for the Leeds Cancer Centre.
Some of the fabulous events Jacqui organised and held last year included ‘Positively Musicals’, which raised an outstanding £9k; ‘Bare All for Cancer’, which raised £5k; ‘Kabaret with Karen’, which raised £2k; and ‘Relive the 80s’, which raised £3k. There was also a group of ten Jacqui’s Million supporters who ran the Leeds 10k and donated an incredible £5k.
Jacqui received the ‘Above & Beyond’ award and ‘Most Inspirational Woman of the Year’ at the Inspire 2022 Awards. She also received the ‘Kate Granger Award for Outstanding Contribution’ at the Yorkshire Choice Awards.
We were thrilled when stalls were welcomed back in Bexley Wing and Jacqui was again able to have her regular stall selling Jacqui’s Million merchandise. The stall always proves popular among staff, patients and those visiting the Cancer Centre, with Jacqui raising awareness and sharing positivity, while also providing peer support to those who need it.
In total, more than £63k was raised through Jacqui’s Million last year – a truly outstanding amount. Thanks to Jacqui’s Million, we have been able to offer funding of around £52k for a bereavement nurse for the second year running to meet increasing demand from families and staff. We have also provided fluorescence assessment software costing more than £3k, which will increase cancer detection rates and consistency in cancer identification and improve outcomes for patients.
**£63k** raised through Jacqui’s Millions
**£9k** Positively Musicals **£5k** Bare All for Cancer
**£2k** Kabaret with Karen
Annual report and financial statements 2022/23
29
Contents
**Ian Flatt**
## **Kevin Sinfield OBE**
Kevin Sinfield OBE is one of our amazing supporters who helped raise vital funds for the Rob Burrow Centre for Motor Neurone Disease Appeal this year, through his series of challenges. We are also forever inspired by, and grateful to Ian Flatt, who completed his Snowden Trek, and to many, many others. It has been an astounding team effort!
## **“**
People living with MND have no choice but to live with their condition every day and they are inspiration for all of us taking part in the challenge. We also need to help those living with MND, to give them hope and love so they know we are with them.” **Kevin Sinfield OBE**
Annual report and financial statements 2022/23
30
Contents
## **Corporate**
This year, corporate fundraising has raised over £0.3m through collaboration with the business community to help the staff and patients of Leeds Teaching Hospitals NHS Trust.
Planning for the Leeds Bear Hunt public art trail has opened doors to new corporate partners across Leeds and the wider region, offering a great way for businesses to engage with employees, clients and the community in a unique way. By 31 March 2023, we had 26 sponsors who had chosen their bear design and trail location and were eagerly waiting to see it come to life in July 2023. We have a good mix of sponsors from a range of industries supporting the campaign, including presenting partners Leeds Bid and Leeds City Council, and official supporters Longs of Leeds, First Direct Bank and RE.
Commercial partnerships continue to be an area of strength. Our existing partnership with toy retailer The Entertainer, supported by financial technology charity Pennies, gives customers within selected stores the option to add a donation in support of Leeds Children’s Hospital at the point of sale. The scheme raised £19k this year alone, giving a total of more than £51k since the partnership began.
Our ‘Sponsor the Sparkle’ campaign got even bigger this year, following a request to add 20 new stars on Clarendon Wing by the team at Leeds Children’s Hospital. Along with the existing 60 stars lighting up Brotherton Wing at Leeds General Infirmary and the 20 stars illuminating Bexley Wing, these new stars helped to bring festive cheer to staff, patients and visitors throughout December. A virtual switchon event was held, with local boxing superstar Josh Warrington delivering the official countdown. The campaign has raised more than £0.1m collectively thanks to the generosity of business across Yorkshire, helping us to bring the sparkle year after year.
Finally, support from the business community for the Rob Burrow Centre for Motor Neurone Disease has been incredible. To date, corporate donations have contributed more than £0.1m to the current fundraising total. A couple of highlights include HH Construction, who fundraised £12k through a charity scheme at work, and High Performance Limited, who donated £11k following an appearance from Lindsey Burrow on their podcast.
**£0.3m**
raised through collaboration with the business community
Paul Watkins, Director of Fundraising, pictured alongside representatives from Leeds Bear Hunt presenting partners Leeds Bid and Leeds City Council.
Annual report and financial statements 2022/23
31
Contents
## **Major donors, trusts and foundations**
The generosity of major donors, trusts and foundations in 2022/23 has enabled our hospitals to go above and beyond for patients, families and staff. The donations we’ve received have helped to fund a variety of innovative and life-saving projects across Leeds Teaching Hospitals that fall outside of statutory NHS funding, and we’re incredibly grateful for that support.
**----- Start of picture text -----**
Leeds Hospitals Charity has been able to purchase an
EPIQ CVx cardiac scanner for the neonatal ward at Leeds
Children’s Hospital tanks to donations received from the
Yorkshire Charity Clay Day Event.
**----- End of picture text -----**
Thank you to the following donors, from whom we received a gift of £10k or more:
**Beaverbrooks Charitable Trust**
**Biswas Foundation**
- **Caddick Group**
- **Cystic Fibrosis Trust**
- **Felicity King**
**Geoff and Fiona Squire Foundation**
**Marjorie & Arnold Ziff Foundation**
- **Medical Research Council – UK Research & Innovation**
**NHS Charities Together**
**Richard Hayes**
- **Samantha and Lucy Charity**
- **Tolkien Trust**
- **Victor and Anne Boughton**
Leeds Teaching Hospitals NHS Trust is a worldleading Centre of Excellence in Research and Innovation. Supported by our Charity, it contributes to scientific breakthroughs that continuously improve healthcare for patients across the globe. Much of this work would not be possible without major donors, Trusts and Foundations, whose donations fund the delivery of world-class treatment, provide cuttingedge technology to improve patient outcomes and invest in pioneering research to enhance our understanding of diseases and how best to treat them. Just a few examples from 2022/23 include:
- **Sonosite ultrasound:** A donation from the Beaverbrooks Charitable Trust funded a Sonosite ultrasound to help with PICC line insertions for cancer patients. A PICC line is a long, thin tube that is inserted through a vein in the patient’s arm and passed through to the larger veins near their heart. This is to enable medication to be pumped quickly and efficiently around the body to where it is needed. The Sonosite ultrasound provides incredibly sharp images to locate and identify the correct vein to insert the line.
- **Neonatal care:** Expectant parents wait a long time to meet their new arrivals and take them home, but sometimes babies are born early or have health complications requiring them to spend their first few months in hospital. A donation of £28k from the Samantha and Lucy Charity funded the life-saving work of the Leeds Neonatal Service taking care babies until they are well enough to go home.
- **Early-career researchers:** A donation of £0.9m from UK Research & Innovation to support the work of early-career researchers allowed the Charity to meet a strategic objective of investing
in research, people and development. Research-active hospitals deliver better care, attract greater talent and foster more opportunities to find solutions for the future. The gift has contributed enormously to the world-leading research programme at Leeds Teaching Hospitals.
- **Neuroblastoma paediatric positioning aid:** The continued generosity of the Geoff & Fiona Squire Foundation funded a positioning aid to enable SPECTCT scans to be performed on patients with suspected neuroblastoma, a cancer that affects babies and children (mostly under the age of five). This equipment will help provide more detailed 3D imaging for doctors to make timely and accurate diagnoses to benefit patients from across Yorkshire.
- **Hospital Fundraising Officer:** A generous donation
- of £30k from NHS Charities Together helped to strengthen fundraising capacity at Leeds Hospitals Charity. This gift was made to fund the post of a Hospital Fundraising Officer, who will be responsible for engaging and building exceptional relationships with patients, families and hospital staff to help the Charity generate more income. This will enable us to further support our hospitals to provide the best possible patient experience.
- **Rob Burrow Centre for Motor Neurone Disease:**
- Several major donors, Trusts and Foundations have contributed to our appeal to fund the building of the Rob Burrow Centre for MND at Seacroft Hospital. This has ensured we are now much closer to realising the vision for the UK’s first MND care centre to be designed and built around the needs of MND patients and their families. This project will be completed by summer 2025.
Annual report and financial statements 2022/23
32
Contents
## **Legacies**
We are incredibly grateful for the support we receive from individuals who have made provisions for Leeds Hospitals Charity in their will. In 2022/23, legacy income amounted to £0.7m and was added to unrestricted funds, unrestricted funds designated by the Trustees for specific purpose, or restricted funds, as appropriate.
The following legacies supported a wide range of projects across Leeds Teaching Hospitals NHS Trust:
- Meum Margaret Adele Brewer left £5k each for the benefit of the Yorkshire Heart Centre and Seacroft Hospital
- Sybil Hewitt left £82k for the benefit of Leeds Cancer Centre
- Kathleen Sawyer left £10k for the benefit of the Kidney Unit
- Roy Ernest Hare left £45k for the benefit of Wharfedale Hospital
- Arnold Reg Morley left £25k for the benefit of the general purposes fund
- Doreen Jones left £15k for the benefit of the general purposes fund
Many more generous pecuniary and residuary gifts were left to benefit various other areas of the hospitals, including several for general purpose funds which enables the gift to be used where need is greatest.
The Charity ran its first multi-channel legacy campaign in 2022/23, resulting in a marked increase in people visiting our website to find out more about gifts in wills. The campaign ran across social media and via external advertising on public transport, billboards and digital screens, as well as in magazines and local newspapers.
March 2023 also saw us launch our Make a Will Month on social media with fantastic results. In a two-week period from 21 to 31 March, 3,722 people visited the website. A local solicitor with whom we partnered had to close its appointments due to demand from supporters!
**Regular giving** Regular sources of income are extremely important to the Charity because they help us to plan ahead, which **81%** is why we launched our regular giving programme, Friends of Leeds Hospitals Charity, in 2020. Regular sources of income are extremely important to the Charity because they help us to plan ahead, which of regular givers remained is why we launched our regular giving programme, committed to supporting Friends of Leeds Hospitals Charity, in 2020.[8] the Charity
Since then, the programme has gone from strength to strength, and we want to say a huge thank you to the almost 5,000 regular givers for their incredible support in 2022/23.
**£7.30**
This year, £0.4m was raised to help make our hospitals even better for patients and families. Our average gift was £7.30 per month and the number of regular givers increased by 25% from 2021/22, with 81% of regular givers remaining committed to supporting the charity. Next year, we plan to continue to grow the number of regular gifts by direct debit with the launch of our ‘Become a Friend’ campaign, which will involve a mix of digital, face-to-face, direct mail and print media.
average monthly gift from our donors
**£0.7 million** Our legacy income in 2022/3
- Kevin John Phipps left £75k for benefit of the Cystic Fibrosis Unit
- Christine Mary Jenkinson left £2k for the benefit
- of the Haematology Department.
Annual report and financial statements 2022/23
33
Contents
## **Lottery**
This year marked the first anniversary of our lottery and saw its in-house management and administration move to the Individual Giving team.
The lottery has a strong appeal within the Leeds community, particularly on our hospital sites. In the past 12 months, we have signed up over 2,000 new players, with 1,743 of those joining made up of patients and staff at St James’s University Hospital, Leeds General Infirmary and Wharfedale Hospital.
The number of monthly entries grew from 5,989 in 2021/22 to 14,672 in 2022/23, an increase of almost 150%, and we now have 6,864 weekly players in total.
Growing the number of players of our lottery continues to be one of our key priorities. To support this, we have now recruited our own team of face-to-face fundraisers to work across hospital sites and at events, promoting the lottery and the positive impact playing can have on the lives of local people.
## **Jackpot winner**
Since the lottery’s launch in 2021, we’ve given out more than £85k in prizes to lucky winners like Marella, who signed up after being diagnosed with a brain tumour secondary to her lung cancer.
For Marella, her monthly donation was a way of giving back for the amazing care and support she’s received at Leeds Cancer Centre: “The staff all the way from the cleaners to the top consultants, nurses and doctors have been absolutely wonderful. I can’t begin to thank them, and I will never be able to thank them enough,” she explains.
Marella was shocked when she received a call telling her she’d won the £1k jackpot prize! The win has meant she’s been able to treat her family, who have been there for her since she was diagnosed with cancer, and make special memories with her grandchildren.
**----- Start of picture text -----**
Volunteers pictured in the Leeds Hospitals Charity shop
**----- End of picture text -----**
## **Retail**
Despite challenging market conditions, we have made progress in diversifying our income streams by expanding our retail operations in 2022/23. To boost our efforts, we took our retail offering online, launching on virtual selling platforms such as eBay. However, our ‘bricks-and-mortar’ offering remains strong, and in December we also refurbished our on-site store in the Bexley Wing at St James’s University Hospital, which is now open to the public.
To make it easier for donors to contribute their preloved items to our cause, we launched an online booking system for collections in Leeds, offering a doorstep collection service. We also placed donation bins at five key hospital sites: St James’s, Leeds General Infirmary, Seacroft, Wharfedale and Chapel Allerton. These initiatives not only strengthened our presence in the community, but also contributed to an increase in the number of items sold, with 48,027 transactions completed in 2022/23.
Also contributing significantly to our success this year were our in-store volunteers, without whom we would not be able to provide the physical shopping experience supporters love. We would like to thank them profusely for the 11,113 hours they have volunteered during the year.
Marella won the jackpot in the Leeds Hospitals Charity Lottery.
Unfortunately, our plans to open more retail units in 2022/23 were hampered by the competitiveness of the commercial retail market. Despite this setback, we remain committed to expanding our retail operations and will continue to explore opportunities to do so in the coming year.
Annual report and financial statements 2022/23
34
Contents
## **Our volunteers**
## **Our volunteer strategy**
Volunteers are essential to Leeds Hospitals Charity in delivering our strategy and goals. From supporting us in our retail stores and hospitals to representing us out and about in our community, the time our volunteers give and the vital funds they help us raise directly impacts staff and patients across all areas of our work.
As we reach the end of year two of our volunteer strategy, we’re proud to reflect on some key successes against our goals.
**Goal 1: Be a volunteer team that reflects the city we live in**
We are thrilled to have significantly grown our volunteer team this year. We have worked hard to nurture positive and long-lasting relationships with partner organisations across the city that support our aim to recruit volunteers of all backgrounds, abilities, skills and experiences.
To support our ambitious ongoing recruitment targets, we completed a vital project to update our visual media assets in 2022/23, and we want to thank all the volunteers that gave their time to make that happen. We are delighted that the new photography and videography truly reflects our incredible volunteer team.
**12,440 hours** donated by volunteers
**303** people volunteered at least once
## **Goal 2: Work together and in partnership**
## **Goal 3: Be the best volunteer experience for all**
We held our first volunteer celebration
We have continued to work positively
with Leeds Teaching Hospitals Voluntary Services team. With their guidance, we successfully reintroduced volunteers to their roles at the piano and in the shop in the Bexley Wing Cancer Centre after a two-and-a-half-year pause due to Covid-19. We now have almost 50 volunteers
event at Leeds City Museum in November to say thank you to our incredible volunteers. Over 50 volunteers and their plus ones attended, with delicious food generously donated by My Lahore. The event was a huge success, and we cannot wait for the next one!
covering the rotas in both roles and this is making a real impact on the Bexley patients and staff, and the Charity as a whole.
We continued our commitment to training new staff members in their volunteer management responsibilities and rolled out e-learning for retail staff on managing a diverse team in retail.
We are also grateful for the ongoing support of the University of Leeds, Leeds Beckett University, Voluntary Action Leeds and Leeds City College – among many others – in continuing to promote our roles to their amazing students and clients.
Through our ongoing partnership with Shipley College, we delivered three bespoke customer service courses, with 22 volunteers and 4 staff achieving a City & Guilds Level 2 Diploma in Customer Service this year – a huge well done to each of them.
A big thank you for all of your efforts. Sincerely, I appreciate Leeds Hospitals Charity for putting us forward to gain numerous achievements.
**----- Start of picture text -----**
“
**----- End of picture text -----**
**Amodu, Retail Volunteer**
## **Goal 4: Embed volunteer best practice to support the Charity’s goals**
We doubled our support at this year’s Children’s Toddle, our 1k walk for under4s, with 45 volunteers donating their time on the day in a variety of roles. It was our second year supporting the Toddle and we had ambitious volunteer targets for the event, which we were able to meet thanks to improved recruitment techniques and embedded onboarding processes. Our experiences from 2021 also allowed us to offer an even more positive experience to volunteers on the day.
We are quietly confident in achieving our ongoing targets for recruiting volunteers into roles and activities across the Charity. Many in the sector continue to paint a sad picture of declining volunteer numbers across the UK; we felt these impacts during the first half of 2022, yet we are now bucking this trend with extremely healthy recruitment figures. Long may it continue, and thank you to every single volunteer who chooses to donate their time to support Leeds Hospitals Charity.
Annual report and financial statements 2022/23
35
Contents
Financial
review
p•ts• •*
Annual report and financial statements 2022123
Contents
36
## **Financial review**
In the financial year to 31 March 2023, Leeds Hospitals Charity saw the previous constraints that had been in place due to the pandemic begin to lift. Alongside our volunteers and fundraisers, we were able to access hospital sites again and this has had a positive impact on our fundraised income for the year.
The war in Ukraine and the ensuing economic impact with increasing fuel prices, spiralling inflation and rising interest rates, however, has had a detrimental impact on our investment portfolio.
As we enter the third year of our fiveyear strategy, we’re continuing to focus on growing reliable, annually recurring, unrestricted income streams and diversifying income to mitigate the risk of becoming over-reliant on unpredictable income sources. To this end, the Trustees have invested in recruiting lottery players and regular givers, and expanding the Charity’s retail offering, which has resulted in an increase in our cost of raising funds. This planned activity was monitored on a continuous basis with careful cost control in place throughout and came in below budget.
Thanks to our generous supporters, we generated income of £7.9m in 2022/23. Expenditure, meanwhile, was £3.6m before grant funding, in a year in which we saw the largest number of grants awarded since the charity became independent in 2017.
Due to the significant grants awarded, our charitable activity this year amounted to £14.4m, culminating in a 39.7% net decrease in funds of £12.7m after unrealised investment losses of £2.6m. The total funds of the Charity by the end of the year were £19.3m (2021/22: £32m). These consist of £3.3m endowed funds (2021/22: £3.7m), £4.6m restricted funds (2021/22: £6.2m), £6.8m unrestricted designated funds (2021/22: £19.7m) and £4.7m unrestricted general funds (2021/22: £2.4m).
Endowed funds are held for the permanent benefit of the Charity, with the income restricted for a specific purpose. Restricted funds are held for specific purposes. Designated funds are unrestricted funds set aside by the Trustees for specific purposes and can be undesignated by the Trustees for use as unrestricted income.
## **Income**
The outlook for 2022/23 for fundraised income was poor, with many negatively impacted by the cost-of-living crisis and having less disposable income to donate. Despite this, our supporters continued to give generously, and income has in fact grown, increasing by 11% (£0.8m) to £7.9m (2021/22: £7.1m) this year.
The mix of donations received has altered since the previous year: 36%, £2.8m (2021/22: 47%, £3.4m) of the current year’s income has been received through donations from individuals, clubs and societies, the reduction reflecting the difficult economic circumstances surrounding the costof-living crisis and individuals’ ability to give to charity.
Our biggest source of income – 42% (2021/22: 60%) – is attributed to donations. Perhaps unsurprisingly, we have seen a reduction in donation income of £1.1m, but this has been tempered by an increase in both our grant income (£0.8m) and our trading activity income (£0.65m) due to growth in the lottery (£0.2m) and increased fundraising events and activity (£0.4m) in the year.
Generous support from charitable trusts and associations, meanwhile, generated 3%, £0.3m of our total income (2021/22: 5%, £0.3m), and our corporate partners contributed 2%, £0.14m (2021/22: 4%, £0.3m). Gifts in kind (included in ‘Donations – other’) continued to be received throughout the year: gifts of £0.06m (2021/22: £0.3m) were donated through the charity to Leeds Teaching Hospitals.
**----- Start of picture text -----**
|||||||
|---|---|---|---|---|---|
|2022/23|2022/23|2021/22|2021/22|
|£’000|% of|£’000|% of|
|income|income|
|Donations – individuals, clubs and societies|2,803|36|3,390|47|
|Donations – charitable trusts and associations|281|3|342|5|
|Donations – corporate|145|2|316|4|11%|
|Donations – other|58|1|299|4|
|Total income from donations|3,287|42|4,347|60|
|Grants|1,505|19|695|10|
|Legacies|718|9|568|8|Total income|
|89|
|Charitable activities|62|1|44|1|has increased|
|Trading|1,421|18|769|11|by 11% (£0.8m)|
|Income from investments and other income|897|11|724|10|
|to £7.9m|
|7,890|100|7,147|100|
**----- End of picture text -----**
**Total income has increased by 11% (£0.8m) to £7.9m**
Annual report and financial statements 2022/23
37
Contents
£897k Grant income has increased by 116 % to £1.5m **116%** (2021/22: £0.7m); this includes £0.9m received from the Medical Research Council to fund early career researchers. Legacy income has increased by 26.5% to £0.7m (2021/22: £0.6m). Total income from donations, grants and legacies has reduced by 1.8% to £5.5m (2021/22: £5.6m). £2.8m **84%** Income from charitable activities such as running educational courses and conferences was £0.06m £1.4m in the year (2021/22: £0.04m). Income from trading activities, meanwhile, has increased by 84% to £1.42m **Income** (2021/22: £0.77m). This is due to the loosening of Covid-19 pandemic restrictions, which meant the Fundraising team was **23.6%** able to restart the events programme, resulting in **£7.9m** an increase in income from fundraising activities and events of £0.4m to £0.9m (2021/22: £0.5m). Growing this unrestricted income is a critical aspect of the £62k Charity’s five-year strategy, ensuring the marketing and communication strategy can be met and activities run in order to attract additional fundraising as well as covering the support costs, needed to ensure that the **24.3%%** Charity is well run and governed. £718k Investment income has increased by 23.6% to £0.89m £281k (2021/22: £0.72m) year on year. £145k £58k **Donations Grants** £1.5m Individuals, clubs and societies **Legacies 1.8%** charitable trusts and associations **Charitable activities** corporate **Trading** other **Investments and other income**
Grant income has increased by 116 % to £1.5m
Income from trading activities, has increased by 84% to £1.4m
Investment income has increased by 23.6% to £0.9m
**24.3%%**
Despite reducing by 24.3%, donations are still our biggest source of income at 42% (2021/22: 60%) of total income
Total income from donations, grants and legacies combined has reduced by 1.8% to £5.5m (2021/22: £5.6m)
Annual report and financial statements 2022/23
38
Contents
## **Expenditure**
The total expenditure for the Charity has increased by 105% (£9.2m) to £18m (2021/22: £8.8m). Of that total, 80% was in respect of charitable activities. The Trustees decided to utilise a proportion of the reserves of the Charity in order to award grant funding, resulting in the grants awarded exceeding the £7.9m total income received by £5.2m.
Spending on our charitable activities, including attributable support costs, has increased by 162% (£8.9m) to £14.4m (2021/22: £5.5m) in the year. The two largest factors contributing to this significant increase are a £6.8m grant awarded for the Rob Burrow Centre for Motor Neurone Disease in Leeds and an award of £2.7m towards the Child Health Outcomes Research in Leeds (CHORAL) project. A total of 281 charitable grants were awarded in the year across our six priority funding areas. The details of our charitable activities this year are set out in sections 5 and 7 of this report and note 5 to the financial statements.
This year has seen a planned increase in spending in order to raise funds: costs of generating funds have increased by 10% (£0.3m) to £3.6m (2021/22: £3.3m). This increase is in line with our strategy to invest in the future growth of unrestricted income, generated through the operation of a lottery, running charity shops selling donated goods and recruiting new regular givers.
The Trustees continue to monitor costs closely and review progress in line with strategy; despite this, the Charity has not been immune to spiralling inflation and the cost-of-living crisis during the year. As a result, the support costs of the Charity have increased in year by 16% (£0.2m) to £1.6m (2021/22: £1.4m). These costs cover teams such as Finance, Information Technology, Human Resources, Communications and Governance. They are set out in note 4 to the financial statements.
## **Reserves policy and management**
The Trustees are aware of their general legal duty to apply the income of the Charity for its purposes within a reasonable period of receipt, and within that framework have reviewed the Charity’s needs for reserves in line with the guidance issued by the Charity Commission.
Free reserves, as defined by the Charity Commission, are unrestricted reserves that are freely available to spend on charitable purposes.
Reserves are an inherent part of the risk management process. The need for reserves will vary depending on our financial position and our assessment of the risks the Charity faces at a particular time.
Leeds Hospitals Charity needs to retain some reserve of funds to ensure the continued furtherance of its objectives. These free unrestricted funds are required:
to enable the Charity to maintain its level of grants to beneficiaries;
to enable the Charity to address financial contingencies as they arise;
to enable the Charity to meet its strategic objectives as set out in the 2021–2026 strategy document;
to protect the Charity from investment market risk;
to provide funds which can be designated to specific projects to enable these projects to be undertaken at short notice; and to provide funds to cover administration, fundraising and support costs without which the Charity could not function.
Given the unpredictable nature of the Charity’s income, the Trustees have a target level of free reserves designed to cover the risks as set out above. This target level is projected as £5.8m for 2022/23 (2021/22: £5.8m). Annual running costs have increased due to the current economic climate and in order to continue investment in the lottery, retail operations and regular giving campaigns,
all of which contribute to the Charity’s
five-year strategy to increase unrestricted income. This minimum level has remained unchanged from the prior year and is to mitigate against risks, as well as covering staff costs and overheads as approved by the Trustees to ensure that the Charity can fulfil its objectives and meet its financial commitments as they fall due.
Unrestricted funds held by the Charity have reduced by £10.7m to £11.4m (2021/22: £22.1m) at the balance sheet date. Of these, £6.8m (2021/22: £12.5m) are designated by the Trustees for specific purposes and £0.02m (2021/22: £0.04m) are held as tangible fixed assets. This leaves free reserves of £4.7m (2021/22: £2.4m) which, while below the current target of £5.8m, is an increase of £2.3m on the prior year.
The Trustees appointed a task and finish group to review all charitable funds, with a focus on the then over 470 unrestricted designated funds. The purpose of this element of the group’s work was to ensure that the designations in place continue to be appropriate, and that funds are being used in a timely manner. As a result, we reduced the number of these funds to 268 at the year end and have continued to reduce further post-year end. The work of the task and finish group has now been completed but the number of designated funds will be kept under annual review. There is one fund materially in deficit at the close of this financial year: the Rob
Burrow Centre for Motor Neurone Disease appeal. The Trustees undertook to award grant funding of £6.8m, underwriting the cost of the Centre’s build. This liability is held on the balance sheet at the year end while fundraising continues. The Trustees are confident that the necessary funds will be raised to meet this current deficit.
The major projects unrealised gain pool designated fund has been set aside for use on major projects within Leeds Teaching Hospitals NHS Trust and also provides protection to the Charity from investment risk. Given that the value of investments can go down as well as up, the Trustees believe that a prudent level of reserves is necessary to ensure the Charity can run efficiently and meet the needs of our beneficiaries. During the year, the Trustees approved the transfer of £3.4m from the major projects unrealised gains fund into free reserves in order to move towards the free reserves target level of £5.8m.
## **Investment policy and performance**
The Trustees’ powers of investment are set out in the Trustee Act 2000, which allows the Trustees to invest the assets of the Charity in investments of any nature as they see fit, subject to a provision to avoid speculative and hazardous investments. As part of good governance of the Charity, the Trustees commenced a tendering
Annual report and financial statements 2022/23
39
Contents
exercise in 2022/23 for investment managers. Ten investment management firms were invited, and all ten accepted the invitation. After a robust process, the Trustees reappointed Rathbones as their investment managers at their Board meeting in June 2023. The firm provides a six-monthly presentation and produces a bi-monthly valuation and activity report, culminating in an annual valuation.
The Trustees seek to balance ethical and socially responsible investment and risk. As such, the investment managers appointed by the Trustees are restricted from investing directly in the processing and/or manufacture of tobacco products. The portfolio is widely diversified, with an equity-based approach. Such an approach balances the greater risk posed by equitybased investment with the potential for higher returns.
Total investments are £33.9m, of which £5.4m were held as cash by our investment managers. Performance is monitored against set benchmarks as agreed with our investment managers on a quarterly basis.
This has been a challenging year, with the downturn in investment value experienced in Q4 of 2021/22 continuing into 2022/23. The war in Ukraine presented a challenge to the economy and inflation continued to rise from 7% Consumer Price Index (CPI) in March 2022 to 10.1% CPI by March 2023, having peaked at 11.1% in October 2022. The central banks also embarked on the fastest interest rate hiking cycle in
history. The collapse of Silicon Valley Bank The asset allocation was as follows at the year end: two days before the collapse of Signature Bank in March 2023 shook global markets, **Asset class 31 March 2023** sending equities around the world **Value (£k) Weight (%)** plummeting.
|**Asset class**|**31 March**|**2023**|31 March|2022|
|---|---|---|---|---|
||**Value (£k)**|**Weight (%)**|Value (£k)|Weight (%)|
|Fixed interest|**5,497**|**16.2**|4,333|11.8|
|Equities – UK|**9,388**|**27.7**|11,475|31.4|
|Equities – overseas|**8,949**|**26.4**|11,519|31.5|
|Alternatives|**4,660**|**13.8**|4,556|12.4|
|Cash|**5,389**|**15.9**|4,706|12.9|
||**33,883**|**100**|36,589|100|
As a result, there were unrealised losses in our portfolio of £2.6m for the year ended 31 March 2023; however, the Charity’s portfolios are invested for the long term and fluctuate year on year, with the expectation of delivering a positive return in the future.
## **Pensions**
## **Going concern**
On 31 March 2023, £4m cash is held by Rathbones in a Capital Reserve account. Since the year end, £3m of this has been transferred into high interest earning time deposit accounts.
Leeds Hospitals Charity provides a defined
These financial statements have been prepared on a going concern basis. At the end of the 2022/23 financial year, Leeds Hospitals Charity held total net assets of £19m (2021/22: £32m), of which £4.7m are free reserves. The diversification of income streams during the year has protected the underlying net asset position in challenging circumstances; the reduction in net assets is due to significantly increased charitable activity in the year. The Trustees have reviewed and approved both the budget for the year to 31 March 2024 and the five-year financial forecast and are confident that there are sufficient unrestricted free reserves to meet the Charity’s commitments as they fall due. The Charity maintains an adequate cash position to meet its ongoing expenditure requirements.
contribution pension scheme for staff, managed by Scottish Widows. The Charity contributes 5% of employee salaries to the scheme, which is matched by the employee. Enrolment is automatic unless individual employees elect not to join the scheme or are not eligible. There are no other material pension liabilities affecting the Charity.
Rathbones achieved a 12-month return of -5.7% (2021/22: 6.5%) compared with the agreed benchmark of -1.9% (2021/22: 8.4%). The yield on the portfolio was 2.9% (2021/22: 2%).
The value of the portfolio has reduced in 2022/23 due to the unrealised losses experienced. There has been no disinvestment of the portfolio in the year. The projected yield has increased from 1.9% to 2.6%
Annual report and financial statements 2022/23
40
Contents
## **Principal risks and uncertainties**
The strategic risk register records the key risks to the Charity and is reviewed by the Audit and Risk Committee and the Board of Trustees at every meeting.
The highest-rated risks in 2022/23 have been to income: the uncertainties posed by the UK’s gradually worsening economic situation, its slow recovery from the impact of the pandemic and the consequent challenging position for individuals and organisations. The Charity’s ability to raise funds has, however, benefitted hugely from two major boosts to our public profile: the support of Kevin Sinfield OBE for the appeal to fund the building of the Rob Burrow Centre for Motor Neurone Disease, and a considerable brand refreshment, including a new logo.
Working relationships with Leeds Teaching Hospitals staff have continued to improve, aided by an increased profile following the opening up of trust premises post-pandemic.
The risk associated with the delay in funding approval for the new hospital build and its potential effect on wider fundraising will be reassessed now that the decision about the new hospital in Leeds has been announced.
**----- Start of picture text -----**
Dr Michelle Kwok-Williams is a Consultant Clinical Oncologist at Leeds Cancer Centre where Leeds Hospitals Charity has
funded state-of-the art radiotherapy equipment such as the MRI-Simulator, and welcoming extras, such as ambient lighting
in treatment rooms for children, to enhance patient’s treatment experiences. She also runs Unity – The After Cure Choir
which we help to support.
**----- End of picture text -----**
Annual report and financial statements 2022/23
41
Contents
41
ProSTEP
4•
About us
Annual report and financial statements 2022123
Contents
42
## **Plans for future years**
As we enter year three of our five-year strategy, we continue to work towards safeguarding the Charity’s future through diversifying our income. Our three key pilot areas of fundraising investment – our regular giving programme, our retail operation and our weekly public lottery – remain the Charity’s best opportunity to grow unrestricted income which will enable us to direct funds quickly to where need is greatest. As such, we will continue to focus our efforts towards growing their reach.
Members of our Friends of Leeds Hospitals Charity individual regular giving programme grew from 4,000 to 5,000 in 2022/23, with a strong recommitment rate of 81%. To achieve our target regular givers by direct debit in year three, plans are in motion for a multimedia recruitment campaign: ‘Become a Friend’.
In year three, we will also revisit our plans to add to our two retail units by opening further shops, in anticipation that the market for commercial retail space may become less competitive.
Having brought the recruitment of our weekly lottery players in-house, the next year will see us continue to grow the number of regular players and entries as we work towards our key objective of producing over £3 million income each year by close of year five and beyond. Our Leeds Hospitals Charity face-to-face fundraisers will work across all hospital sites and at events to target our most interested demographics: Leeds Teaching Hospitals patients, families and staff.
All of the above rely on an increase in visibility for the Charity, something which we have started to build since the end of pandemic restrictions enabled staff and volunteers to return to hospitals sites. The planned rollout of our new brand assets in year three will boost our public profile and should greatly facilitate our aims.
Embedding our new brand isn’t just about visual impact, it’s also about embedding our values of transformation, transparency and working together, which underpin everything we do. A prime example of how our values drive our charitable activity can be seen in the launch of our fundraising appeal to raise £6.8 million (net) for the Rob Burrow Centre for Motor Neurone Disease. The centre has the potential to transform the lives of hundreds of MND patients across our region but needs strong partnerships and a collaborative approach to succeed. By working closely with colleagues across Leeds Teaching Hospitals and delivering a cross-team campaign, we’ve already succeeded in raising over half of our fundraising target in less than a year.
Another major initiative with which we anticipate moving forward in the next year is the Children’s Hospital Capital Appeal (as part of the Hospitals of the Future Programme). After a long delay, it was confirmed by the Government that the New Hospitals Programme cohort 3 schemes, of which Leeds is part, would be fully funded and delivered by 2030. This news will necessitate decisions around the reinstatement of our Capital Appeal Board and give
us fresh opportunities to promote our work with Leeds Children’s Hospital across Leeds and beyond.
Outside of ongoing work, this third year of our strategy is a transitional one in many ways, as we seek to embed a new funding structure and find ways of making the application process more accessible for NHS staff in order to maximise our impact. We’re also looking to gain greater understanding of that impact by applying the theory of change model to our work.
## **Equality, diversity and inclusion**
Our work on equality, diversity and inclusion continues to be a significant priority. Mandatory training is now in place for all our employees, both the current workforce and new starters. We will continue to build on the work already undertaken to ensure we are in the best position to create a culture and environment that is equitable and inclusive and that recognises, encourages and celebrates diversity. This includes identifying meaningful actions to take in response to the feedback we have collated from working groups, and embedding equality, diversity and inclusion into our business plan. We will also continue to engage with staff and build on the training and development we have already provided to existing staff by offering further internal and external educational sessions, both face to face and via our online portal.
Annual report and financial statements 2022/23
43
Contents
## **Structure, governance and management**
Leeds Hospitals Charity is registered as a charity with the Charity Commission in England (registered number 1170369) and at Companies House as a company limited by guarantee (registered number 10492128).
Since 4 January 2021, the Charity has operated under the working name of Leeds Hospitals Charity, although the legal entity remained Leeds Cares. The change to the new legal entity was confirmed in July 2023.
The Trustees confirm that Leeds Hospitals Charity operates in compliance with the Companies Act 2006; the Charities Act 2011; the Accounting and Reporting by Charities: Statement of Recommended Practice 2019 (SORP) and other applicable accounting structures; and the provisions of the Memorandum and Articles of Association of the organisation.
The Charity is registered with the Fundraising Regulator. The Charity has established a trading subsidiary, LHC Enterprise Ltd (registered number 13438357), in anticipation of increasing trading activity, but this has remained dormant throughout 2022/23.
## **Memorandum of Understanding**
A Memorandum of Understanding continues to underpin the relationship between Leeds Hospitals Charity and Leeds Teaching Hospitals, demonstrating our shared commitment to working collaboratively to deliver benefits to patients and their families. A review of the Memorandum of Understanding was completed during 2021/22 and signed by the Boards of Leeds
Teaching Hospitals Trust and the Charity on 10 March 2022. It reflects the evolution of the relationship between the two organisations since the creation of the Charity. The Memorandum will be reviewed again during 2023/24.
## **Compliance**
Leeds Hospitals Charity complies with the provisions of the Data Protection Act 2018 and the UK General Data Protection Regulation (GDPR), in so far as they apply to its operations, and is registered with the Information Commissioner’s Office (reference number ZA480848).
Leeds Hospitals Charity has confirmed that the scale of its operations does not require the appointment of a Data Protection Officer; instead, the Charity has a senior responsible officer. There is a policy in place to investigate and report breaches of the legislation. During 2022/23, four minor breaches (2021/22: six) were reported locally and investigated; these did not reach the threshold which would require reporting to the Information Commissioner. Staff have demonstrated that they are open and keen to improve when breaches occur. Thorough investigations were undertaken, and lessons learned were communicated to the staff to prevent recurrence.
Leeds Hospitals Charity is also registered and complies with the Code of Fundraising Practice.
## **Risk management strategy**
The risk management policy and framework provided a sound basis for risk management throughout 2021/22 but its fundamentals have been reviewed during 2022/23. Elements of a new framework have been adopted by the Board of Trustees as the year has progressed, with familiarisation and training underway in preparation for full implementation in 2023/24.
The Board of Trustees has reviewed the strategic risk register, which is considered monthly by the Executive Leadership team and quarterly by the Audit and Risk Committee and the Board of Trustees, while the Board Committees have reviewed the pertinent operational risk registers that are owned at manager level and updated by all staff as appropriate. These risk registers are considered monthly by middle and senior management and each risk, whether strategic or operational, is assessed against a matrix that measures likelihood and consequence, both before and after controls have been applied, and sets a target risk score – which reflects broadly the risk appetite of the Trustees. Risks are added as they are identified, and a date is set for achievement of the target risk score. When this is achieved, the risk is usually archived; archived risks are reviewed on a periodic basis. Some risks which have reached their target risk score are retained for monitoring as part of a ‘watching brief’ on potentially recurring risks.
## **Complaints**
A complaints policy is in place and is applicable to all complaints received by Leeds Hospitals Charity. During 2022/23, a more streamlined process has been put in place to reflect the larger number of complaints received and to track more accurately the progress of resolution. The accompanying complaints register records details of the complaint and the complainant and the outcomes of the investigative processes, including a review if necessary. If complaints cannot be resolved internally by Leeds Hospitals Charity using the complaints policy, then there is provision for reference to the appropriate regulators.
During 2022/23, a total of 59 complaints (2021/22: 24) was received by the Charity. This significant increase on an already elevated total in the previous year was anticipated to a degree because the more active approach to fundraising taken by the Charity was considered likely to generate more complaints. For context, 56 of the 59 complaints involved either fundraising methods utilised by agency staff engaged to increase regular giving and lottery subscriptions, or the principle of recruiting in this way. All the complaints (including these) were resolved without referral to regulators. It is anticipated that the number of complaints in the forthcoming year will reduce significantly as supporter recruitment is brought in-house.
Annual report and financial statements 2022/23
44
Contents
## **Trustees and Committees**
Leeds Hospitals Charity has a fully independent Board of Trustees, whose members are appointed as Directors of Leeds Hospitals Charity (Company Number: 10492128), and is incorporated under the Companies Act 2006 as a private company.
There were 12 Trustees at 31 March 2023. Additional Trustees are appointed by the incumbent Trustees, under the Articles of Association. In addition, there are three non-voting Associate Trustees in development roles.
The Board of Trustees meets at least four times a year and is responsible for providing strategic leadership and governance for Leeds Hospitals Charity. The Board of Trustees has met in person and, exceptionally, virtually during the year, and hybrid options are made available to Trustees when required to maximise attendance. All meetings of the Board Committees during the year have taken place virtually. The Chief Executive of Leeds Hospitals Charity and the Executive Leadership team also attend all meetings of the Trustees, and selected staff members continue to attend as observers at Committee meetings to strengthen links between the Trustees and staff.
When necessary, additional _ad hoc_ meetings are convened to deal with specific matters or to give the Board of Trustees the opportunity to discuss strategic issues in greater depth. There has been one such meeting in 2022/23, covering the launch of the appeal for funding to build the Rob Burrow Centre for Motor Neurone Disease. Some decisions which require early resolution are taken out of committee, or with authority delegated to the Chair of Trustees, and then recorded and reported at the next available Board meeting.
The Trustees are responsible both individually and collectively for the proper management of funds and are answerable to the Charity Commission. They are duty bound to ensure that all funds within their responsibility are spent in accordance with the wishes of the donor and the charitable Objects of Leeds Hospitals Charity.
The Trustees have set clear objectives against which the Charity can assess its performance. The Trustees’ role in these is to ensure:
demonstrably effective management of funds
provision of additional equipment and environmental enhancements to Leeds Teaching Hospitals
support for research and innovation
support for training and education
assistance with major planned developments.
More specifically, the Board of Trustees undertakes the following duties:
- overseeing strategic plans for fundraising and other operations
approving the allocation of charitable expenditure
approving business plans and budgets
reviewing operating and financial performance at every meeting
overseeing Committees of the Board of Trustees.
An annual skills and diversity audit was completed during the year to identify those skill sets which were not available within the current Board of Trustees. The audit indicated a need to improve its diversity. Although improvements have been made, there continues to be more work to be done, especially around improving the diversity of the Board to better represent the communities which the Charity serves.
The Trustees have a legal obligation to act in the best interests of Leeds Hospitals Charity in accordance with the Charity’s governing documents. Conflicts of interest may arise where an individual’s or a related party’s business, personal or family interests and/or loyalties conflict with those of the Charity. This may also involve links where influence may be exerted without a specific, identifiable conflict of interest. All Trustees declare their interests in writing, using the Leeds Hospitals Charity declaration of interest form, and the register is published on the Charity’s website. Trustees confirm annually that the information held continues to be relevant, accurate and complete, and this is audited during the year-end process.
In addition, prior to the commencement of each quarterly meeting of the Board of Trustees and Board Committees, Trustees declare any conflicts of interest which have either changed or are particularly relevant to business on the agenda for that meeting.
There are six Board Committees which undertake detailed scrutiny of particular issues, address regulatory or statutory requirements and provide advice on aspects of the objectives of Leeds Hospitals Charity. The Committees have agreed terms of reference which are reviewed and approved at least annually by the Board. The Board of Trustees appoints a Trustee with the appropriate skills and experience to be the Chair of each Committee, and
other Trustees make up the membership. All Trustees are invited to attend all Committee meetings should they so wish. Leeds Hospitals Charity staff – as well as representatives from Leeds Teaching Hospitals NHS Trust and other stakeholders – are invited to attend the meetings to ensure strategic alignment and provide expertise where appropriate. Highlight reports are presented by Committee Chairs at each quarterly Board meeting and the draft minutes of Committee meetings are available to Trustees.
The six Committees of the Board which operated during 2022/23 were as follows.
## **Finance and Performance Committee**
This Committee oversees all matters relating to finance and performance, including budget setting, quarterly monitoring of financial matters and the review of key performance indicators. The Committee has at least three Trustees as members and is normally chaired by a financially qualified Trustee. This year the Committee has been chaired by Mr Jonathan Grant and, in his absence, by Professor Peter McWilliam.
Annual report and financial statements 2022/23
45
Contents
## **Research and Innovation Committee**
This Committee makes decisions on applications for funding for research and innovation with a value of greater than £10k, where the funding is within the grants budget. Applications with a value up to £10k are made by the Small Grants Panel, chaired by the Chief Executive, and reported to the Committee on a quarterly basis. Applications for over £10k where there is no funding available in the budget are recommended to the Board of Trustees for a decision. The Committee has at least three Trustees as members and is chaired by Professor Peter McWilliam.
Following the admission of Leeds Hospitals Charity to membership of the Association of Medical Research Charities, an independent Scientific Advisory Panel has been established with the remit to examine the scientific value and relevance of research and innovation applications. Dr Jonathan Sheffield OBE is the Chair of the Panel, which makes recommendations to the Committee and has no authority to make funding decisions on behalf of the Charity.
## **Funding Committee**
This Committee makes decisions on applications for funding (other than for research and innovation) with a value greater than £10k, where the funding is within the grants budget. Applications with a value up to £10k are made to the Small Grants Panel, chaired by the Chief Executive, and reported to the Committee on a quarterly basis. Applications for over £10k where there is no funding available in the budget are recommended to the Board of Trustees for a decision. The Committee has at least three Trustees as members and is chaired by Cllr Caroline Gruen.
the Research and Innovation and Funding
Committees ensure that they take the opportunity to hear first-hand from award holders and beneficiaries of funding about the impact that the charitable funding has made. In addition, where it is appropriate applicants are invited to present their proposal to support transparent, fair and well-informed decision- making.
## **Audit and Risk Committee**
This Committee is accountable to the Board for the acquisition and scrutiny of assurances, oversight and advice for the Board on matters relating to the effective design and operation of risk management, financial governance, internal financial controls and internal and external audit of Leeds Hospitals Charity. The Committee has a minimum of three Trustees as members, at least one of whom has recent and relevant financial experience, ideally a professional qualification from one of the professional accountancy bodies. It is chaired by Mr Chris Schofield. The Chair of the Board of Trustees is not a member of this Committee but is invited to attend one meeting each year to discuss the Annual Report and Accounts.
## **Income Generation and Communications Committee**
This Committee focuses on the strategic direction of Leeds Hospitals Charity as a proactive fundraising organisation. It is accountable to the Board of Trustees for advising on branding and communications; approving annual fundraising budgets; monitoring the fundraising performance of the Charity; agreeing any remedial actions that need to be taken to meet fundraising targets; and scrutinising fundraising proposals for consideration of the Board where these are not within the authority
of the Committee for approval. At least three Trustees are members, and the Committee is chaired by Mr Edward Ziff. Charity staff attend meetings of these Committees to provide specialist input and advice.
## **Remuneration Committee**
This Committee meets in private session as and when required. The Committee considers and approves recommendations for changes to the salary levels and terms and conditions of the Chief Executive and the four Executive Directors. It is chaired by the Chair of the Board of Trustees, Mr Edward Ziff.
## **Appointment of Trustees**
Leeds Hospitals Charity is committed to appointing Trustees with a range of experience and qualifications to ensure that the Board is diverse and has the necessary skills to discharge its responsibilities. There have been no new Trustee appointments during 2022/23.
All appointments are made on merit, based on recommendations to the Board made by an interview panel consisting of a number of Trustees and advised by the Chief Executive and the Company Secretary. The process is open, transparent and fair for applicants. A range of sources for applicants are employed, with wide search criteria used to expand the pool. A shortlist of candidates is compiled based on the specific skills and experience they could bring to the post, to ensure that those skills not currently represented on the Board can be added. A thorough pre-appointment process is undertaken – including declarations of business or commercial interest and the Fit and Proper Persons test – before the selected candidate(s) are proposed to the Board for approval at a quarterly meeting. Following their appointment, Trustees undergo a comprehensive induction process
during which they are provided with guidance on being a Trustee, including provision of the Charity Commission’s ‘The Essential Trustee: What you need to know, what you need to do (CC3)’, which explains the duties of a Trustee and the role of the Board. Also included are elements of the Leeds Teaching Hospitals NHS Trust induction process to ensure that new Trustees begin to understand the relationship with, and scope of, the major beneficiary of the Charity. Trustees are required to sign the Trustee Code of Conduct, which encompasses the Nolan Committee guiding principles.
Annual report and financial statements 2022/23
46
Contents
## **Reference and administrative details**
## **Name and registered numbers**
Leeds Hospitals Charity (from 27 July 2023)
Leeds Cares (1 April 2022 – 26 July 2023)
- Registered Charity Number: 1170369
Companies House Number: 10492128
## **Governing document**
‘Memorandum and Articles’ incorporated 22 November 2016; as amended by Scheme dated 29 March 2017; as amended by Special Resolution registered at Companies House on 15 May 2018; as amended by Special Resolution registered at Companies House on 24 November 2020.
## **Leeds Hospitals Charity charitable Objects**
The charitable Objects of the Charity, as defined in law, are:
- a) to further any charitable purpose or purposes relating to the general or specific purposes of the NHS Trust or the purposes of the Health Service;
- b) to promote, protect, preserve and advance all or any aspects of the health of the public;
- c) to advance and promote knowledge and education in medicine and health including by engaging in and supporting medical and health research and the dissemination of the useful results.
## **Professional advisers**
## **Bankers**
National Westminster Bank plc
Leeds City Office, 8 Park Row Leeds LS1 5HD
Clydesdale Bank Plc (also trading as Virgin
Money,Yorkshire Bank) 94-96 Briggate Leeds LS1 6NP
## **Investment managers**
Rathbones
- 159 New Bond Street
London W1S 2UD
## **External auditors**
## **Solicitors**
Withers LLP 16 Old Bailey London EC4M 7EG
Wrigleys Solicitors LLP 3rd Floor
- 3 Wellington Place Leeds LS1 4AP
MacRoberts LLP
Capella 60 York Street Glasgow G2 8JX
Mazars LLP
## **Principal and registered office**
Ground Floor, Trust Headquarters Beckett Street St James’s University Hospital Leeds LS9 7TF
Tel: 0113 20 65173 13
## **Linked charities**
Leeds Hospitals Charity encompasses 12 linked charities that share this Trustees’ Report and single set of aggregated accounts. The linked charities share the same charity number as Leeds Hospitals Charity, have the same Trustees and are connected because of the services they provide. Full details are in section 6 of this report.
- 5th Floor
- 3 Wellington Place Leeds LS1 4AP
Annual report and financial statements 2022/23
47
Contents
## **Statement of Trustee responsibilities and accounts**
The Trustees are responsible for preparing the Trustees’ Report and the financial statements in accordance with charity and company law.
Company law requires the Trustees to prepare financial statements for each financial year. Under that law, the Trustees have elected to prepare the financial statements in accordance with UK Generally Accepted Accounting Practice (UK Accounting Standards and applicable law). Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing those financial statements, the Trustees are required to:
- select suitable accounting policies and then apply them consistently;
The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The Trustees also confirm that, as far as they are aware, there is no relevant audit information of which the Charity’s auditors are unaware, and they have taken all steps that they ought to have taken as Directors in order to make themselves aware of any relevant audit information and to establish that the Charity’s auditors are aware of that information.
- observe the methods and principles in the Charities SORP;
observe the methods and principles in the In approving the Directors’ and Trustees Report on Charities SORP; pages 4 to 47 the Trustees are also approving the strategic report therein, see page 7, in their capacity make judgements and estimates that are as Company Directors. reasonable and prudent;
By Order of the Board of Trustees.
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
Signed:
Jonathan Grant, Trustee Edward Ziff, Chair Date: 21 September 2023 Date: 21 September 2023
Annual report and financial statements 2022/23
48
Contents
11
}J
it
rtan
financial statements
-re
Annual report and financial statements 2022123
Contents
49
## **Independent auditor’s report to the members of Leeds Hospitals Charity**
## **Opinion**
We have audited the financial statements of Leeds Hospitals Charity (the ‘charity) for the year ended 31 March 2023 which comprise Statement of Financial Activities, the Balance Sheet, the Statement of Cash Flows and notes to the financial statements, including a summary of significant accounting policies.
The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (United Kingdom Generally Accepted Accounting Practice).
In our opinion, the financial statements: give a true and fair view of the state of the charity’s affairs as at 31 March 2023 and of its deficit for the year then ended;
- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
- have been prepared in accordance with the requirements of the Companies Act 2006.
## **Basis for opinion**
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs
(UK)) and applicable law. Our responsibilities under those standards are further described in the “Auditor’s responsibilities for the audit of the financial statements” section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
## **Conclusions relating to going concern**
In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorized for issue.
Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.
## **Other information**
The other information comprises the information
included in the trustees’ report, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.
Our responsibility is to read the other information and,
in doing so, consider whether the other information is materially inconsistent with the financial statements, or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
## We have nothing to report in this regard. **Opinions on other matters prescribed by the Companies Act 2006**
In our opinion, based on the work undertaken in the course of the audit:
the information given in the trustees’ report and the directors’ report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
The trustees’ report and the directors’ report have been prepared in accordance with applicable legal requirements.
## **Matters on which we are required to report by exception**
In light of the knowledge and understanding of the charity and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors’ report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion: adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or the financial statements are not in agreement with the accounting records and returns; or certain disclosures of directors’ remuneration specified by law are not made; or we have not received all the information and explanations we require for our audit.
Annual report and financial statements 2022/23
50
Contents
## **Responsibilities of Trustees**
As explained more fully in the Statement of Trustee responsibility and accounts’ section on page 47, the Trustees (who are also the Directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the Trustees are responsible for assessing the Charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the Charity or to cease operations, or have no realistic alternative but to do so.
## **Auditor’s responsibilities for the audit of the financial statements**
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor’s Report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.
Irregularities, including fraud, are instances of noncompliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. Based on our understanding of the Charity and its sector, we considered that non-compliance with the following laws and regulations Charities Act 2011 the Charities Statement of Recommended Practice, UK tax legislation, pensions legislation and employment regulation and we considered the extent to which non-compliance might have a material effect on the financial statements.
To help us identify instances of non-compliance with these laws and regulations, and in identifying and assessing the risks of material misstatement in respect to non-compliance, our procedures included, but were not limited to:
inquiring of management and, where appropriate, those charged with governance, as to whether the Charity is in compliance with laws and regulations, and discussing their policies and procedures regarding compliance with laws and regulations; inspecting correspondence, if any, with relevant licensing or regulatory authorities; communicating identified laws and regulations to the engagement team and remaining alert to any indications of non-compliance throughout our audit; and considering the risk of acts by the Charity which were contrary to applicable laws and regulations, including fraud.
We also considered those laws and regulations that have a direct effect on the preparation of the financial statements, such as such as Charities Act 2011, the Charities Statement of Recommended Practice, UK tax legislation and pensions legislation.
prevention and detection of irregularities including fraud rests with management. As with any audit, there remained a risk of non-detection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal controls.
In addition, we evaluated the Trustees’ and management’s incentives and opportunities for fraudulent manipulation of the financial statements, including the risk of management override of controls, and determined that the principal risks related to posting manual journal entries to manipulate financial performance, management bias through judgements and assumptions in significant accounting estimates, in particular in relation to the treatment of revenue recognition (which we pinpointed to the cut-off assertion), the restriction of income and expenditure, the treatment of liabilities from multi-year grant commitments, the apportionment of indirect costs and significant one-off or unusual transactions.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org. uk/auditorsresponsibilities. This description forms part of our Auditor’s Report.
## **Use of the Audit Report**
This report is made solely to the company’s members as a body in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an Auditor’s Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body for our audit work, for this report, or for the opinions we have formed.
Our audit procedures in relation to fraud included but To the fullest extent permitted by law, we do not were not limited to: accept or assume responsibility to anyone other than the company and the company’s members as a body making enquiries of the Trustees and for our audit work, for this report, or for the opinions management on whether they had knowledge of we have formed. any actual, suspected or alleged fraud; gaining an understanding of the internal controls established to mitigate risks related to fraud; David Hoose (Senior Statutory Auditor) discussing amongst the engagement team the for and on behalf of Mazars LLP risks of fraud; and Chartered Accountants and Statutory Auditor addressing the risks of fraud through 5th Floor management override of controls by performing 3 Wellington Place journal entry testing. Leeds LS1 4AP There are inherent limitations in the audit procedures described above and the primary responsibility for the Date: 10 October 2023
Annual report and financial statements 2022/23
51
Contents
## **Statement of financial activities for the year ended 31 March 2023**
The notes on pages 55–70 form part of these financial statements. This Statement of Financial Activities includes all gains and losses in the year. All income and expenditure derive from continuing activities (see notes 3–7). A comparative statement of financial activities is included in note 21.
||**Income from:**
Donations and legacies|3.1
**Note**|3,701
**Unrestricted**
**funds**
**£000**|1,809
**Restricted**
**funds**
**£000**|-
**Endowment**
**funds**
**£000**|5,510
**2022/23**
**Total funds**
**£000**|5,610
**2021/22**
**Total funds**
**£000**||
|---|---|---|---|---|---|---|---|---|
||Charitable activities|3.2|62|-|-|62|44||
||Other trading activities|3.3|1,244|177|-|1,421|769||
||Investments|10|823|71|-|894|723||
||Other income|3.4|2|1|-|3|1||
||**Total income**||**5,832**|**2,058**|**-**|**7,890**|7,147||
||**Expenditure on:**||||||||
||Raising funds|4.1|3,414|189|12|3,615|3,260||
||**Charitable activities:**|5|||||||
||Equipment||343|337|-|680|1,025||
||Environment||7,760|18|-|7,778|444||
||Supporting specialist staf||116|67|-|183|611||
||Research and innovation||2,902|1,803|-|4,705|1,880||
||Health and wellbeing||157|684|-|841|1,001||
||Education and training||124|3|-|127|69||
||Gifts in kind distributed to benefciaries||62|-|-|62|488||
||**Total expenditure**||**14,878**|**3,101**|**12**|**17,991**|8,778||
||Net(losses)/gains on investments|
7|(1,671)|(585)|(341)|(2,597)|1,926||
||**Net (expenditure)/income**||**(10,717)**|**(1,628)**|**(353)**|**(12,698)**|295||
||Transfers between funds|6|27|(27)|-|-|-||
||**Net movement in funds**||**(10,690)**|**(1,655)**|**(353)**|**(12,698)**|295||
||**Reconciliation of funds:**
Total funds brought forward||22,142|6,204|3,664|32,010|31,715||
||**Total funds carried forward**||**11,452**|**4,549**|**3,311**|**19,312**|32,010||
Annual report and financial statements 2022/23
52
Contents
**Leeds Hospitals Charity Company Number: 10492128**
## **Balance sheet as at 31 March 2023**
|||**Note**|**Unrestricted**
**funds**|**Restricted**
**funds**|**Endowment**
**funds**|**2023**
**Total funds**|**2022**
**Total funds**||
|---|---|---|---|---|---|---|---|---|
||**Fixed assets:**||**£000**|**£000**|**£000**|**£000**|**£000**||
||Tangible assets|9.1|20|-|-|20|43||
||Investments|9.2|19,028|6,397|3,069|28,494|31,883||
||**Total fxed assets**||**19,048**|**6,397**|**3,069**|**28,514**|31,926||
||**Current assets:**||||||||
||Stocks||6|-|-|6|4||
||Debtors|11.1|745|718|-|1,463|1,025||
||Investments|11.2|4,864|283|242|5,389|4,706||
||Cash at bank and in hand||842|-|-|842|1,590||
||**Total current assets**||**6,457**|**1,001**|**242**|**7,700**|7,325||
||**Liabilities:**||||||||
||Creditors: amounts falling
due within one year|12.1|(5,074)|(2,060)|-|(7,134)|(5,683)||
||**Net current assets/(liabilities)**||**1,383**|**(1,059)**|**242**|**566**|1,642||
||||||||||
||**Total assets less current liabilities**||**20,431**|**5,338**|**3,311**|**29,080**|33,568||
||Creditors: amounts falling
due after more than one year
**Total net assets**|12.2|(8,979)
**11,452**|(789)
**4,549**|-
**3,311**|(9,768)
**19,312**|(1,558)
32,010||
||**Funds of the Charity:**
Endowment funds
Restricted income funds|13.2
13.3|-
-|-
4,549|3,311
-|3,311
4,549|3,664
6,204||
||Unrestricted funds|13.4|11,452|-|-|11,452|22,142||
||**Total Charity funds**||**11,452**|**4,549**|**3,311**|**19,312**|32,010||
The notes on pages 55–70 form part of these financial statements.
These financial statements were approved and authorised for issue by the Trustees on 21 September 2023 and signed on their behalf by:
Edward Ziff, Chair Date: 21 September 2023 Contents
53
## **Statement of cash flows for the year ended 31 March 2023**
The notes on pages 55–70 form part of these financial statements.
||**Cash fows from operating activities**
Net cash used in operating activities|17.1
**Note**|**(1,744)**
**31 March 2023**
**£000**|(2,773)
**31 March 2022**
**£000**||
|---|---|---|---|---|---|
||**Cash fows from investing activities**|||||
||Dividends interest and rents from investments|10|**894**|723||
||Proceeds from the sale of investments
Purchase of fxed assets|9.2
9.1|**11,665**
**(7)**|18,411
(48)||
||Purchase of investments|9.2|**(10,873)**|(13,086)||
||**Net cash provided by investing activities**||**1,679**|6,000||
||**Change in cash and cash equivalents in the year**|17.2|**(65)**|3,227||
||Cash and cash equivalents at the beginning of the year||**6,296**|3,069||
||**Cash and cash equivalents at the end of the year**||**6,231**|6,296||
||**Analysis of cash and cash equivalents**|||||
||Cash in hand||**842**|1,590||
||Short-term deposits|11.2|**5,389**|4,706||
||**Total cash and cash equivalents**||**6,231**|6,296||
Annual report and financial statements 2022/23
54
Contents
## **1 Accounting Policies**
## **1.1 Basis of preparation**
The financial statements have been prepared under the historic cost convention, with items recognised at cost or transaction value, with the exception of investments which are included at market value. The financial statements have been prepared in accordance with _Accounting and Reporting by Charities: Statement of Recommended Practice (FRS 102)_ (second edition, October 2019); all applicable UK Accounting Standards; International Reporting Standards; and the Companies Act 2006.
The Charity constitutes a public benefit entity as defined by FRS 102.
## **1.2 Going concern**
The Trustees consider that there are no material uncertainties about the Charity’s ability to continue as a going concern. The Trustees have formed a judgement at the time of approving the financial statements that there is a reasonable expectation that the Charity has access to adequate resources to continue in operational existence for a period of at least 12 months from the date of approval of the accounts.
At the end of the financial year, Leeds Hospitals Charity had total net assets in excess of £19m. The previous constraints concerning restrictions due to the pandemic have been lifted, having a positive impact upon our income from fundraising and events in the year. The Trustees have revisited the forecast results to March 2025 and considered the period of at least 12 months from the date of approval of the accounts and are confident that there are sufficient unrestricted free reserves to meet its commitments as they fall due. The Charity maintains an adequate cash position
to meet its ongoing expenditure requirements. For this reason, the Trustees have adopted the going concern basis in preparing the financial statements.
## **1.3 Tax**
Leeds Hospitals Charity, as a registered charity, is exempt from tax under Part 10 of the Income Tax Act 2007 or Section 256 of the Taxation of the Chargeable Gains Act 1992, to the extent that surpluses are applied to its charitable purpose.
Irrecoverable VAT is charged against the category of expenditure for which it was incurred.
## **1.4 Income**
All income is included in full in the Statement of Financial Activities as soon as the following three factors can be met:
- entitlement (arises when a particular resource is receivable, or the Charity’s right becomes legally enforceable);
- probability (it is more likely than not that the economic benefits will flow to the Charity);
- measurement (when the monetary value of the income can be measured with sufficient reliability).
## **a) Income from legacies**
Legacies are accounted for as income either upon receipt or where the receipt of the legacy is probable. This will be once confirmation has been received from the representatives of the estate(s) that payment of the legacy will be made, or property transferred and once all conditions attached to the legacy have been fulfilled, and when the amount can be estimated with
sufficient reliability.
## **b) Income from investment assets**
Investment income includes income from investment assets, including dividends, interest and rents but excluding realised and unrealised investment gains. Individual unrestricted funds and the majority of restricted funds do not receive a direct allocation of income.
Investment income is utilised by the Trustees to meet the ongoing running costs and grant-making activities
of the Charity.
Endowment funds are invested in a separate portfolio, and the full income received is allocated to associated restricted income funds.
Where such income is not subject to restriction, it would be allocated to an unrestricted income fund. The Charity has no such funds.
## **1.5 Expenditure**
The Charity’s accounts are prepared in accordance with the accruals concept.
Expenditure is recognised when a liability is incurred. Grant commitments are recognised once there is a legal or constructive obligation to make a payment to a third party.
Grants are only made to related or third-party NHS bodies and non-NHS bodies in furtherance of the Charity’s charitable Objects. A liability for such grants is recognised when approval has been given by the Trustees. A grant approval is taken to constitute a firm intention of payment, and so a liability is recognised.
Contractual arrangements are recognised as goods or
services supplied.
**a) Allocation of overhead and support costs**
Overhead and support costs have been allocated as a direct cost or apportioned on an appropriate basis (refer to note 4) between charitable activities and governance costs. Once allocation and/or apportionment of overhead and support costs has been made between charitable activities and governance costs, the cost attributable to charitable activities is apportioned across those activities in proportion to total spend.
## **b) Costs of fundraising**
The costs of fundraising are the costs associated with generating income for the Charity. This includes the costs associated with investment management.
**c) Charitable activities**
Costs of charitable activities comprise all costs incurred in the pursuit of the charitable Objects of the Charity. These costs comprise direct costs and an apportionment of overhead and support costs as shown in note 5.
**d) Governance costs 1.6 Structure of funds**
Governance costs comprise all costs incurred in the governance of the Charity. These costs include costs related to statutory audit, together with an apportionment of overhead and support costs.
Where there is a legal restriction on the purpose to which a fund may be put, the fund is classified in the accounts as a restricted fund. Funds where the capital is held to generate income for charitable purposes and cannot itself be spent are accounted for as permanent endowment funds. The Charity holds no expendable endowment funds.
55
Contents
Other funds are classified as unrestricted funds. Funds which are not legally restricted but which the Trustees have chosen to earmark for set purposes are classified as unrestricted designated funds.
The major funds held within these categories are disclosed in note 13
## **1.7 Accounting judgements and estimates**
In preparing the financial statements, the Trustees have made judgements, estimates and assumptions that affect the application of the Charity’s accounting policies and the reported assets, liabilities, income and expenditure and the disclosures made in the financial statements.
These estimates and judgements are continually reviewed and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
The most significant areas of judgement and key assumptions are:
**a) Multi-year grant commitments liability** Such grants are fully accrued when awarded and unspent amounts held as commitments until either the full award has been spent or the Trustees consider that any residual sums will no longer be required or claimed by grantees. At that point the commitment will be judged complete and cancelled.
Children’s Hospital is one of the Government’s 40 new hospitals set out in their manifesto. While these pledges can be measured and there is a good probability that they will be fulfilled, they were given prior to confirmation of Treasury funding, in a period when there was a Capital Appeal Director and the Capital Appeal Board met regularly.
Due to uncertainty over Treasury funding in the year the Capital Appeal Board ceased to meet after July 2022, and the Capital Appeal Director left the Charity. Since the year end the Charity is delighted that Treasury funding has now been confirmed for the Children’s Hospital. Only once the probability of receipt and entitlement of pledged income is confirmed with these donors will they be recognised as income within these financial statements.
## **1.8 Tangible fixed assets**
Tangible fixed assets are measured at their historical cost. Fixed assets with a cost of more than £1,000 are capitalised and depreciated. These assets are depreciated to write off the cost over their expected useful lives at the following rates:
Computer, other equipment and plant: 4 years
Retail shops fixtures and fittings: over the term of the lease
Depreciation is only charged when assets are brought into operational use.
## **1.9 Fixed asset investments**
Investments are a form of basic financial instrument and are initially recognised at their transaction value and subsequently measured at their fair value as at the balance sheet date using the closing quoted market price. The Statement of Financial Activities includes the net gains and losses arising on revaluation and disposals throughout the year.
The Charity does not acquire options, derivatives or other complex financial instruments. The main form of financial risk faced by the Charity is that of volatility in equity markets and investment markets due to wider economic conditions, the attitude of investors to investment risk, and changes in sentiment concerning equities and within particular sectors or subsectors.
Investment fixed assets are shown at market value. Quoted stocks and shares are included in the balance sheet at mid-market price, ex dividend.
## **1.10 Realised gains and losses**
All gains and losses are taken to the Statement of Financial Activities as they arise.
Realised gains and losses on investments are calculated as the difference between sales proceeds and opening market value (or date of purchase if later).
Unrealised gains and losses are calculated as the difference between market value at the year end and opening market value (or date of purchase if later). Realised and unrealised investment gains and losses are combined in the Statement of Financial Activities.
## **1.11 Pensions costs**
Under the terms of the Pensions Act 2008, the Charity is required to provide a pension scheme for employees. Qualifying employees are enrolled in the Charity’s Workplace Pension, run by Scottish Widows. This is a defined contribution scheme.
There is one employee covered by the provisions of the NHS Pension Schemes (one employee in 2021/22). Details of the benefits payable and rules of the Schemes can be found on the NHS Pensions website (www.nhsbsa.nhs.uk/pensions). Both are unfunded, defined benefit schemes that cover NHS employers, GP practices and other bodies, allowed under the direction of the Secretary of State for Health in England and Wales. They are not designed to be run in a way that would enable the Charity to identify its share of the underlying scheme assets and liabilities. Therefore, each scheme is accounted for as if it were a defined contribution scheme: the cost to the Charity of participating in the schemes is taken as equal to the contributions payable to the schemes for the accounting period.
## **1.12 Cash**
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
**b) Pledged income** Verbal pledges were received by the Charity in 2021/22 in respect of the new Children’s Hospital Capital Appeal, Hospitals of the Future. The new
Annual report and financial statements 2022/23
56
Contents
## **1.13 Financial instruments**
The Charity has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at amortised cost using the effective interest method. Financial assets held at amortised cost comprise cash at bank and in hand, together with trade and other debtors. Financial liabilities held at amortised cost comprise trade and other creditors. Other derivativebased assets included in the investment portfolio are held at their fair value.
## **1.14 Stock**
Stock is valued at the lower of cost and net realisable value. Cost includes all costs of purchase.
## **1.15 Donated goods**
Gifts in kind received in the year have been distributed to beneficiaries and are not held as stock. They are measured at fair value and recognised as income within donations and, when distributed, the expenditure is included within charitable activities.
## **2 Related party transactions**
With the exception of five Trustees – including Mr Edward Ziff, Dame Linda Pollard DBE DL, Mr Mark Davies and Cllr Caroline Gruen – none of the Trustees or members of the key management staff or parties related to them has undertaken any material transactions with Leeds Hospitals Charity during the year.
Mr Edward Ziff is the Chairman and CEO of Town Centre Securities plc, with whom Leeds Hospitals Charity entered into a lease for a charity shop in April 2021. Leeds Hospitals Charity has signed a commercial agreement at arm’s length. The lease agreement is £50,000 plus VAT per annum.
Mr Mark Davies is a Director of Think So Limited, who trade as Think OTB, with whom Leeds Hospitals Charity entered a contract for services in November 2021. The commercial agreement was entered into at arm’s length after a rigorous tender process. The value of the contract was £30,000 including VAT and concluded during the 2022/23 financial year. Mr Davies was not involved in the decision, which was approved by a Resolution of the non-conflicted Trustees. A donation of £3,000 was received in March 2023 from Think OTB towards the Children’s Hospital Appeal Bear Hunt.
Ms Lauren Glaister is a Senior Client Portfolio Manager at ABRDN Capital Ltd. The Charity contract with ABRDN as our pension scheme advisers. A fee is paid to ABRDN for these services. Ms Glaister is not involved in any contractual decisions with respect to the pension scheme.
2023. Mr Athwal was not involved in any contractual decisions and has now resigned from the Board of Trustees.
Cllr Caroline Gruen is a Director of White Rose
Academy Trust, from whom the Charity received a donation of £231 during the year. Cllr Gruen is also a Trustee of Barca-Leeds and a Board member of Bramley Baths, who were awarded £100,092 and £16,550 respectively as part of the NHS Charities Together stage 2 funding which concluded during the 2022/23 financial year. Cllr Gruen was not involved in the distribution of this funding.
Leeds Hospitals Charity has made revenue and capital payments to the Leeds Teaching Hospitals NHS Trust. The Chair of Leeds Teaching Hospitals NHS Trust, Dame Linda Pollard DBE DL, is a Trustee of Leeds Hospitals Charity. Details of Leeds Hospitals Charity’s related party transactions with Leeds Teaching Hospitals NHS Trust are below:
Medical equipment: 49 grants; £694k (2021/22: £1,041k)
Research and innovation: 48 grants; £4,273k (2021/22: £1,571k)
Health and wellbeing: 57 grants; £793k (2021/22: £1,082k)
Education and training: 95 grants; £159k (2021/22: £211k)
Environment: 27 grants; £7,096k (2021/22: £407k)
Specialist staff: 5 grants; £155k (2021/22: £576k)
At 31 March 2023, Leeds Hospitals Charity had total commitments and creditors owing to Leeds Teaching Hospitals NHS Trust of £15m (2021/22: £5.8m). No sums were owed to Leeds Hospitals Charity by the NHS Trust.
Mr Jasbir Athwal is a Board Member of Enable 2. Enable 2 are taking part in the schools project for the Leeds Bear Hunt, which takes place over summer
Annual report and financial statements 2022/23
57
Contents
## **3 Income**
|**3.1 Income from donations and legacies**|**Unrestricted**|**Restricted**|**Total 2023**|**Total 2022**||
|---|---|---|---|---|---|
||**funds**|**funds**|**funds**|**funds**||
||**£000**|**£000**|**£000**|**£000**||
|Donations from individuals, clubs and societies|2,755|48|**2,803**|3,391||
|Donations from charitable trusts and associations|183|98|**281**|342||
|Corporate donations|221|(76)|**145**|316||
|Donations earmarked for research:||||||
|From individuals, clubs and societies|-|-|**-**|1||
|From companies|1|-|**1**|-||
|From pharmaceutical companies|-|-|**-**|1||
|Legacies|501|217|**718**|568||
|Grants|(17)|1,522|**1,505**|695||
|Donatedgoods and services for distribution|57|-|**57**|296||
|**Total income from donations and legacies**|**3,701**|**1,809**|**5,510**|5,610||
|**3.2 Income from charitable activities**||||||
|Income from the provision of education and training|58|-|**58**|44||
|Corporate sponsorship of training events|4|-|**4**|-||
|**Total income from charitable activities**|**62**|**-**|**62**|44||
|**3.3 Income from other trading activities**||||||
|Income from fundraising activities|449|92|**541**|377||
|Lottery income|274|-|**274**|52||
|Sale of donated goods and merchandise|244||**244**|211||
|Income from fundraisingevents|277|85|**362**|129||
|**Total income from other trading activities**|**1,244**|**177**|**1,421**|769||
|**3.4 Other income**||||||
|Other income|2|1|**3**|1||
|**Total other income**|**2**|**1**|**3**|1||
58
Contents
## **4 Expenditure**
|**4 Expenditure**|||||||
|---|---|---|---|---|---|---|
|**4.1 Cost of raising funds**|**Unrestricted**|**Restricted**|**Endowed**|**Total 2023**|**Total 2022**||
||**funds**|**funds**|**funds**|**funds**|**funds**||
||**£000**|**£000**|**£000**|**£000**|**£000**||
|Fundraising events and appeals|1,577|158|-|
**1,735**|1,887||
|Legacies|129|-|-|
**129**|105||
|Charitable trusts and corporate donations|199|31|-|
**230**|196||
|Operation of lottery|778|-|-|
**778**|412||
|Operation of charity shops|319|-|-|
**319**|262||
|Investment broker fees|95|-|12|
**107**|130||
|Support costs allocated|317|-|-|
**317**|268||
|**Total cost of raising funds**|**3,414**|**189**|**12**|
**3,615**|3,260||
|**4.2 Allocation and apportionment of governance costs**|**2023**
**£000**|**2022**
**£000**|**Basis of apportionment**||||
|Salaries, SLA* and related costs|**947**|862||Allocated on time|||
|Legal and consultancy|**233**|219||Allocated on time|||
|Branding and publicity|**125**|112||Allocated on time|||
|Recruitment|**10**|5||Allocated on time|||
|General running costs|**117**|94||Allocated on time|||
|Computer hardware/software licences|**135**|54||Allocated on time|||
|Audit and professional fees|**26**|19||Allocated on time|||
|Bank charges|**15**|11||Allocated on time|||
|**Total**|**1,608**|1,376|||||
*Service Level Agreement
Annual report and financial statements 2022/23
59
Contents
|**4.3 Apportionment of support costs across costs of raising funds**|**Costs**|**of generating**|**Investment**|**Investment**|**Total**|**allocated**|**Total allocated**|||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|||**income**|**management**|**costs**||**2023**|**2022**|||||
|||**£000**||**£000**||**£000**|**£000**|||||
|Salaries, SLA and related costs||149||38||**187**|168|||||
|Legal and consultancy||37||9||**46**|43|||||
|Branding and publicity||20||5||**25**|22|||||
|Recruitment||2||-||**2**|1|||||
|General running costs||18||5||**23**|18|||||
|Computer hardware/software licences||21||5||**26**|10|||||
|Audit and professional fees||4||1||**5**|4|||||
|Bank charges||2||1||**3**|2|||||
|**Total**||**253**||**64**||**317**|268|||||
|**4.4 Apportionment of support costs across charitable activities**|Medical|Environment|Gifts in kind|Specialist staf||Research and|Health and|Education|**Total allocated**|Total allocated||
||equipment|||||innovation|wellbeing|and training|**2023**|2022||
||£000|£000|£000||£000|£000|£000|£000|**£000**|£000||
|Salaries, SLA and related costs|40|407|3||10|245|46|9|**760**|694||
|Legal and consultancy|10|101|1||2|60|11|2|**187**|176||
|Branding and publicity|5|54|1||1|32|6|1|**100**|90||
|Recruitment|-|4|-||-|3|1|-|**8**|4||
|General running costs|5|51|-||1|30|6|1|**94**|76||
|Computer hardware/software licences|6|58|1||1|35|6|1|**108**|44||
|Audit and professional fees|1|11|-||1|7|1|-|**21**|15||
|Bank charges|1|7|-||-|4|1|-|**13**|9||
|**Total**|**68**|**693**|**6**||**16**|**416**|**78**|**14**|**1,291**|1,108||
Annual report and financial statements 2022/23
60
Contents
|**5 Analysis of charitable activities**|**Unrestricted**|**Restricted**|**Support**|**Total**|**Net grant**|**Support**|**Total**||
|---|---|---|---|---|---|---|---|---|
||**funds**|**funds**|**costs**|**2022/23**|**funding**|**costs**|**2021/22**||
||**£000**|**£000**|**£000**|**£000**|**£000**|**£000**|**£000**||
|Medical equipment|275|337|68|**680**|934|91|1,025||
|Environment|7,067|18|693|**7,778**|373|71|444||
|Supporting specialist staf|100|67|16|**183**|554|57|611||
|Research and innovation|2,486|1,803|416|**4,705**|1,445|435|1,880||
|Health and wellbeing|80|684|77|**841**|778|223|1,001||
|Education and training|108|3|16|**127**|30|39|69||
|Gifts in kind distributed to benefciaries|57|-|5|**62**|296|192|488||
|**Total analysis of charitable activities**|**10,173**|**2,912**|**1,291**|**14,376**|4,410|1,108|5,518||
|**5.1 Analysis of grants**||**Total**||**Total**|||||
|||**2022/23**||**2021/22**|||||
|**Name of recipient and number of grants**|**No**|**£000**|**No**|**£000**|||||
|**Grants awarded to institutions**|||||||||
|Leeds Teaching Hospitals NHS Trust – medical equipment|49|694|56|1,041|||||
|Leeds Teaching Hospitals NHS Trust – health and wellbeing|57|793|120|1,082|||||
|Leeds Teaching Hospitals NHS Trust – research and innovation|48|4,273|68|1,571|||||
|Leeds Teaching Hospitals NHS Trust – environment|27|7,096|28|337|||||
|**Revenue grants**|||||||||
|Leeds Teaching Hospitals NHS Trust – specialist staf|5|155|8|575|||||
|**Grants awarded to individuals**|||||||||
|Staf of Leeds Teaching Hospitals NHS Trust – training and development|95|159|85|211|||||
|**Total grants awarded**|**281**|**13,170**|365|4,817|||||
|Gifts in kind distributed to benefciaries|-|57|-|296|||||
|Grants returned, undrawn or written back|217|(142)|618|(703)|||||
|**Total**||**13,085**||4,410|||||
61
Contents
|**6 Details of transfers between funds**|**Unrestricted**|**Restricted**|**Endowed**|**Total 2022/23**|**Total 2021/22**|
|---|---|---|---|---|---|
||**funds**|**funds**|**funds**|**funds**|**funds**|
||**£000**|**£000**|**£000**|**£000**|**£000**|
|Transfers between funds|27|(27)|-|-|-|
The fund transfers are a result of a live fundraising appeal, which had been part of the restricted Hospitals of the Future appeal, being reclassified as unrestricted due to the uncertainty surrounding the Treasury funding for Hospitals of the Future.
|**7 (Losses)/ gains on investments**|**Unrestricted**|**Restricted**|**Endowed**|**Total 2022/23**|**Total 2021/22**|
|---|---|---|---|---|---|
||**funds**|**funds**|**funds**|**funds**|**funds**|
||**£000**|**£000**|**£000**|**£000**|**£000**|
|Realised (losses)/gains on investment asset|(1,179)|(413)|(241)|**(1,833)**|1,099|
|Unrealised (losses)/gains on investment assets|(492)|(172)|(100)|**(764)**|827|
|**Total (losses)/gains on investments**|**(1,671)**|**(585)**|**(341)**|**(2,597)**|1,926|
|**8 Staf costs and emoluments**||||||
|**8.1 Analysis of staf costs**||||**Total 2022/23**|**Total 2021/22**|
|||||**£000**|**£000**|
|Consultancy fees||||||
|||||**2**|36|
|**Salaries and wages**||||**2,081**|1,759|
|**Social security costs**||||**196**|173|
|**Otherpension costs**||||**98**|81|
|||||**2,377**|2,049|
|**Average head count**||||||
|Fundraising staf||||**36**|30|
|Charitable staf||||**27**|26|
62
Contents
|**8.2 Staf emoluments**|**2023**|**2022**|
|---|---|---|
||**No**|**No**|
|£60k and £70k|-|2|
|£70k and £80k|-|1|
|£80k and £90k|3|2|
|£90k and £100k|1|-|
|£100k and £110k|1|-|
## **8.3 Key management personnel remuneration**
The key management personnel of the Charity comprises Trustees, the Chief Executive Officer, Director of Communications, Director of Fundraising, Director of Finance and Corporate Services, and Company Secretary. Trustees are not remunerated. Trustees received no reimbursement of out-ofpocket expenses.
The total cost of employing the Charity’s key management personnel during the year, including employer’s social security and pension contributions, was £475,914 (2021/22: £402,896). The highest paid member of staff was the CEO, whose annual salary was £98,357 (2021/22: £89,476). Leeds Hospitals Charity median salary was £28,000 (2021/22: £28,737) which represents a ratio against the highest salary of 3.51:1. Leeds Hospitals Charity is committed to equal opportunities and offering fair pay and conditions.
|**9 Analysis of fxed assets**|||
|---|---|---|
|**9.1 Tangible fxed assets**|**Fixtures, fttings and equipment**||
||**£000**||
|**Cost**|||
|At 1 April 2022|70||
|Additions|7||
|**At 31 March 2023**|**77**||
|**Depreciation**|||
|At 1 April 2022|27||
|Charge in theyear|30||
|**At 31 March 2023**|**57**||
|**Net book value 31 March 2023**|**20**||
|Net book value 31 March 2022|43||
Annual report and financial statements 2022/23
63
Contents
|**9.2 Investments**
**9.3 Class of investments**
**10 Investment income**
Market value at 1 April 2022
20,874
7,353
3,656
**31,883**
35,282
Add: acquisitions at cost
7,417
2,589
867
**10,873**
13,086
Less: disposals at carrying value
(7,592)
(2,960)
(1,113)
**(11,665)**
(18,411)
Add: net(loss)/gain on revaluation
(1,671)
(585)
(341)
**(2,597)**
1,926
**Market value at 31 March 2023**
**19,028**
**6,397**
**3,069**
**28,494**
31,883
Historic cost
**26,895**
25,771
Fixed interest
**5,497**
4,333
Equities – UK
**9,388**
11,475
Equities – overseas
**8,949**
11,519
Alternatives
**4,660**
4,556
**28,494**
31,883
Investments – dividends received
**750**
675
Investments – interest received
**144**
48
Total investment income
**894**
723
**Unrestricted**
**funds**
**£000**
**Restricted**
**funds**
**£000**
**Endowed**
**funds**
**£000**
**Total 2023**
**£000**
**Total 2023**
**£000**
**Total 2023**
**£000**
**Total 2022**
**£000**
**Total 2022**
**£000**
**Total 2022**
**£000**|**11 Analysis of current a**|**11 Analysis of current a**|
|---|---|---|
||**11.1 Debtors**
Trade debtors
Accrued income
Other debtors|**705**
39
**757**
936
**1**
50
**31 March**
**2023**
**£000**
**31 March**
**2022**
**£000**|
||**Total debtors falling due within one**|**year**
**1,463**
1,025|
||**11.2 Investments**
Rathbones Capital Reserve Cash Acc
Rathbones Capital Reserve Cash Acc|ount
**5,147**
4,702
ount(B)
**242**
4
**31 March**
**2023**
**£000**
**31 March**
**2022**
**£000**|
||**Total short-term investments and de**|**posits**
**5,389**
4,706|
||**12 Analysis of liabilitie**
**12.1 Creditors under one yea**
Trade creditors
Accruals
Taxation and social security|**s**
**r**
**1,115**
585
**5,963**
5,048
**56**
50
**31 March**
**2023**
**£000**
**31 March**
**2022**
**£000**|
||**Total creditors falling due within one**|**year**
**7,134**
5,683|
||**12.2 Creditors over one year**||
## **11 Analysis of current assets**
||**11.1 Debtors**|**31 March**|**31 March**||
|---|---|---|---|---|
|||**2023**|**2022**||
|||**£000**|**£000**||
||Trade debtors|**705**|39||
||Accrued income|**757**|936||
||Other debtors|**1**|50||
||**Total debtors falling due within one year**|**1,463**|1,025||
||**11.2 Investments**|**31 March**
**2023**|**31 March**
**2022**||
|||**£000**|**£000**||
||Rathbones Capital Reserve Cash Account|**5,147**|4,702||
||Rathbones Capital Reserve Cash Account(B)|**242**|4||
||**Total short-term investments and deposits**|**5,389**|4,706||
||**12 Analysis of liabilities**||||
||**12.1 Creditors under one year**|**31 March**|**31 March**||
|||**2023**|**2022**||
|||**£000**|**£000**||
||Trade creditors|**1,115**|585||
||Accruals|**5,963**|5,048||
||Taxation and social security|**56**|50||
||**Total creditors falling due within one year**|**7,134**|5,683||
||**12.2 Creditors over one year**|**31 March**|**31 March**||
|||**2023**|**2022**||
|||**£000**|**£000**||
||Accruals forgrantspayable|**9,768**|1,558||
||**Total creditors falling due after more than one year**|**9,768**|1,558||
64
Contents
## **13 Analysis of funds**
|**13.1**|**Movement in funds 2022/23**||||**Balance**|**Movement**|**Balance**||
|---|---|---|---|---|---|---|---|---|
||||||**1 April**|**in year**|**31 March**||
||||||**£000**|**£000**|**£000**||
|**Funds**|||||||||
||Unrestricted general purpose||||2,489|2,174|**4,663**||
||Unrestricted designated||||19,653|(12,864)|**6,789**||
||Restricted||||6,204|(1,655)|**4,549**||
||Endowments||||3,664|(353)|**3,311**||
||**Total**||||**32,010**|**(12,698)**|**19,312**||
|**Movement in funds 2021/22**|||||||||
|**Funds**|||||||||
||Unrestricted general purpose||||3,800|(1,311)|**2,489**||
||Unrestricted designated||||18,993|660|**19,653**||
||Restricted||||5,545|659|**6,204**||
||Endowments||||3,377|287|**3,66**||
||**Total**||||**31,715**|**295**|**32,010**||
|**13.2 Endowment funds**||**Balance**|**Income**|**Expenditure**|**Transfers**|**Gains &**|**Balance**||
|||**1 April**||||**losses**|**31 March**||
|||**2022**||||**£000**|**2023**||
|||**£000**|**£000**|**£000**|**£000**||**£000**||
|A Elsie May Sykes Fund||2,208|-|(7)|-|(200)|**2,001**||
|B JeremyNeil Allen||1,456|-|(5)|-|(141)|**1,310**||
|**Total**||**3,664**|**-**|**(12)**|**-**|**(341)**|**3,311**||
|**Name of fund**||**Description of the nature and**||**purpose of fund**|||||
- A Elsie May Sykes Fund Funding of research and equipment at Leeds Teaching Hospitals NHS Trust. B Jeremy Neil Allen Funding of paediatric oncology research, Paediatric Service, Oncology.
Annual report and financial statements 2022/23
65
Contents
|**13.3**|**Restricted funds, including linked charities**|**Balance**|**Income**|**Expenditure**|**Transfers**|**Gains &**|**Balance**||
|---|---|---|---|---|---|---|---|---|
|All funds with either an opening balance exceeding £250,000 or material activity in the year are stated separately below.||**1 April**
**2022**||||**losses**|**31 March**
**2023**||
|||**£000**|**£000**|**£000**|**£000**|**£000**|**£000**||
||**Material funds**||||||||
|A|Arthritis and Infammatory Diseases Charity (formerly the Infammation Group Fund)|486|25|137|-|(116)|**532**||
|B|Leeds Cancer Centre Charity|1,912|102|(527)|-|(157)|**1,330**||
|C|Breast Cancer Research Action Group|942|26|(93)|-|(80)|**795**||
|D|Liaison Psychiatry|644|-|(179)|-|(52)|**413**||
|E|Paediatric Oncology Research – Jeremy Neil Allen|177|29|(30)|-|(31)|**145**||
|F|Neurosurgical Research – Philip Moore legacy|274|-|(137)|-|(37)|**100**||
|G|Stroke Research – Raymond Bucktrout legacy|519|-|(134)|-|(42)|**343**||
|H|NHS Charities Together|74|579|(517)|-|-|**136**||
|I|UKRI – Medical Research Council|-|926|(926)|-|-|**-**||
||Others(17):|1,176|371|(695)|(27)|(70)|**755**||
||**Total**|**6,204**|**2,058**|**(3,101)**|**(27)**|**(585)**|**4,549**||
## **Details of material funds – restricted funds**
**Name of fund Status Description of the nature and purpose of fund**
- A Arthritis and Inflammatory Diseases Charity
- B Leeds Cancer Centre Charity C Breast Cancer Research Action Group D Liaison Psychiatry E Paediatric Oncology Research F Neurosurgical Research G Stroke Research H NHS Charities Together I UKRI – Medical Research Council
- Linked Funding of research and therapy for arthritis and autoimmune candidates. Linked Funding of research, equipment and enhanced patient care. Linked Funding of research into breast cancer and purchase of equipment. Funding for the benefit of the Department of Psychiatry.
- Income from the Jeremy Neil Allen endowment restricted for paediatric oncology research.
- Income from the Philip Moore legacy restricted for neurosurgical research.
- Income from the Raymond Bucktrout legacy restricted for stroke research.
- Restricted grant income from NHS Charities Together.
- Restricted grant for early-career researchers from the Medical Research Council (MRC) part of the UK Research and Innovation (UKRI).
Annual report and financial statements 2022/23
66
Contents
|**13.4**|**Unrestricted funds**|**Balance**|**Income**|**Expenditure**|**Transfers**|**Gains &**|**Balance**||
|---|---|---|---|---|---|---|---|---|
|||**1 April**||||**losses**|**31 March**||
|All funds with either an opening balance exceeding £250,000 or material activity in the year are stated separately below.||**2022**|||||**2023**||
|||**£000**|**£000**|**£000**|**£000**|**£000**|**£000**||
||**Material designated funds**||||||||
|A|Leukaemia Research|543|33|(576)|-|-|**-**||
|B|Children’s Tumour & Leukaemia Fund|320|-|(320)|-|-|**-**||
|C|Yorkshire Cancer Centre|1,134|400|(1,089)|-|-|**445**||
|D|Academic Chair in Clinical Oncology|442|-|-|-|-|**442**||
|E|Children’s Services Charity|26|387|(24)|-|-|**389**||
|F|Motor Neurone Disease Unit|1,776|2,054|(6,963)|-|-|**(3,133)**||
|G|Critical Care Charity Fund|282|21|14|-|-|**317**||
|H|Kidney Care Charity Fund|363|21|(34)|-|-|**350**||
|I|Major Projects|7,110|-|-|(3,400)|(1,671)|**2,039**||
||Other designated funds(259):|7,657|371|(2,209)|121|-|**5,940**||
||**Designated funds**|**19,653**|**3,287**|**(11,201)**|**(3,279)**|**(1,671)**|**6,789**||
||**General unrestricted fund**|**2,489**|**2,545**|**(3,677)**|**3,306**|-|**4,663**||
||**Total**|**22,142**|**5,832**|**(14,878)**|**27**|**(1,671)**|**11,452**||
## **Details of material funds - unrestricted designated funds**
**Name of fund Description of the nature and purpose of fund, and approximate timeframe for expenditure**
- A Leukaemia Research B Children’s Tumour & Leukaemia Fund C Yorkshire Cancer Centre D Academic Chair in Clinical Oncology E Children’s Services Charity F Motor Neurone Disease Unit G Critical Care Charity Fund H Kidney Care Charity Fund I Major Projects
- Funding of leukaemia research, 3–5 years. Funding of research, equipment, and staff training and development, 3–5 years. Funding of research, equipment and enhanced patient care, 3–5 years. Funding of research, 3–5 years.
- Funding of equipment, facilities and enhanced patient care at Leeds Children’s Hospital, 3–5 years. Funding of equipment, facilities and enhanced patient care for patients with motor neurone disease, 3–5 years. To enhance the treatment and care of patients requiring critical care at Leeds Teaching Hospitals, 3–5 years. To enhance the care and treatment of patients requiring renal services in Leeds, 3–5 years.
- Unrealised Gains on Investment Portfolio, designated for use on major projects within Leeds Teaching Hospitals NHS Trust in line with the Charity’s strategy and objectives, 5–10 years.
Annual report and financial statements 2022/23
67
Contents
|**13.5 Analysis of net assets between funds 2022/23**|**Unrestricted funds**|**Unrestricted funds**|**Restricted**|**funds**|**Total funds**||
|---|---|---|---|---|---|---|
||**General**|**Designated**|**Restricted**|**Endowed**|**2023**||
||**funds**|**funds**|**funds**|**funds**|||
||**£000**|**£000**|**£000**|**£000**|**£000**||
|Fixed assets|20|-|-|-|**20**||
|Investments|-|19,028|6,397|3,069|**28,494**||
|Stock|6|-|-|-|**6**||
|Debtors|321|424|718|-|**1,463**||
|Cash investments|5,351|(487)|283|242|**5,389**||
|Cash at bank and in hand|842|-|-|-|**842**||
|Liabilities due within one year|(1,492)|(3,582)|(2,060)|-|**(7,134)**||
|Liabilities due after more than oneyear|(385)|(8,594)|(789)|-|**(9,768)**||
|**Total net assets**|**4,663**|**6,789**|**4,549**|**3,311**|**19,312**||
|**Analysis of net assets between funds 2021/22**|**Unrestricted funds**||**Restricted**|**funds**|**Total funds**||
||**General**|**Designated**|**Restricted**|**Endowed**|**2022**||
||**funds**|**funds**|**funds**|**funds**|**£000**||
||**£000**|**£000**|**£000**|**£000**|||
|Fixed assets|43|-|-|-|**43**||
|Investments|-|20,875|7,352|3,656|**31,883**||
|Stock|4|-|-|-|**4**||
|Debtors|606|287|132|-|**1,025**||
|Cash investments|3,650|1,017|34|5|**4,706**||
|Cash at bank and in hand|379|669|539|3|**1,590**||
|Liabilities due within one year|(1,868)|(2,591)|(1,224)|-|**(5,683)**||
|Liabilities due after more than one year|(325)|(604)|(629)|-|**(1,558)**||
|**Total net assets**|**2,489**|**19,653**|**6,204**|**3,664**|**32,010**||
## **14 Legacies**
Legacy income is only included in income where receipt is probable, and the amount is capable of being estimated with sufficient reliability or has been received. Legacies recognised in 2022/23 totalled £718k. The following exceeded £50k:
Joan Margaret Kale for the benefit of Leeds Cancer Centre Margaret Joan Abraham for the benefit of the Cardiology Unit Sheila Dodd for the benefit of the Heart Unit
68
Contents
|**15 Financial instruments**|**2022/23**|**2021/22**||
|---|---|---|---|
||**£000**|**£000**||
|Financial assets measured at amortised cost|1,463|1,025||
|Financial liabilities measured at amortised cost|16,846|7,191||
|Financial assets comprise accrued income. Financial liabilities comprise accruals including grants.||||
|**16 Trustee and connected persons transactions**|**Total**|**Total**||
||**2022/23**|**2021/22**||
|**16.1 Trustee indemnity insurance**|**£000**|**£000**||
|Description of cover||||
|Markel (UK) Limited:||||
|Social Welfare Combined Insurance Cover|**11**|8||
|Total|**11**|8||
|**17 Cash fow**||||
|**17.1 Reconciliation of net (expenditure)/income to net cash fow from operating activities**|**2022/23**|**2021/22**||
||**£000**|**£000**||
|Net (expenditure)/income for the year|**(12,698)**|295||
|**Adjustment for:**||||
|Depreciation charges|**30**|27||
|Losses/(gains) on investments|**2,597**|(1,926)||
|Dividends, interest and rents from investments|**(894)**|(723)||
|Increase in stock|**(3)**|(4)||
|(Increase)/decrease in debtors|**(438)**|482||
|Increase/(decrease) in creditors|**9,662**|(924)||
|**Net cash used in operating activities**|**(1,744)**|(2,773)||
Annual report and financial statements 2022/23
69
Contents
|**17.2**|**Analysis of changes in net debt**|**Balance 1**
**April 2022**|**Cash fows in**
**year**|**Balance 31**
**March 2023**||
|---|---|---|---|---|---|
|||**£000**|**£000**|**£000**||
|Cash|in hand and at bank|1,590|(748)|**842**||
|Cash|equivalent|4,706|683|**5,389**||
|**Total**||6,296|(65)|**6,231**||
## **18 Auditor’s remuneration**
The auditor’s remuneration of £23,100 relates solely to the 2022/23 audit (2021/22: £19,200).
|**19 Operating lease commitments**|**<1 year**|**1–5 years**|**>5 years**|
|---|---|---|---|
||**£000**|**£000**|**£000**|
|Land and buildings|12|-|-|
## **20 Contingent liabilities**
The Charity has given indemnities to executors under the standard terms for legacies received from dormant accounts. The Trustees believe the risk of significant claims arising as a result of these to be negligible.
## **21 Statement of Financial Activities for the year ended 31 March 2022**
|||**Unrestricted**|**Restricted**|**Endowment**|**2021/22**||
|---|---|---|---|---|---|---|
|||**funds**|**funds**|**funds**|**total funds**||
|||**£000**|**£000**|**£000**|**£000**||
||**Income from:**||||||
||Donations and legacies|4,096|1,514|-|5,610||
||Charitable activities|44|-|-|44||
||Other trading activities|709|60|-|769||
||Investments|650|73|-|723||
||Other income|1|-|-|1||
||**Total income**|**5,500**|**1,647**|**-**|**7,147**||
||**Expenditure on:**||||||
||Raising funds|3,027|218|15|3,260||
||**Charitable activities:**||||||
||Equipment|712|313|-|1,025||
||Environment|413|31|-|444||
||Support specialist staf|570|41|-|611||
||Research and innovation|1,584|296|-|1,880||
||Health and wellbeing
Education and training|542
36|459
33|-
-|1,001
69||
||Gifts in kind distributed to benefciaries
**Total expenditure**|488
**7,372**|-
**1,391**|-
**15**|488
**8,778**||
||Net gains on investments|1,211|413|302|1,926||
||Transfers between funds|10|(10)|-|-||
||**Net movement in funds**|**(651)**|**659**|**287**|**295**||
||**Reconciliation of funds**||||||
||Total funds brought forward|22,793|5,545|3,377|31,715||
||**Total funds carried forward**|**22,142**|**6,204**|**3,664**|**32,010**||
70
Contents
Leeds
Hospitals
Charity
"I want the best
cancer treatment
to be available for
patients like me."
Merton
Help fund pioneering treatments for
more patients like Merton.
Remember Leeds Hospitals Charity
in your Will today.
www.leedshospitalscharity.org.uk
Registered Charity No. 1170369